WO2011080738A1 - Endovascular flow direction indicator - Google Patents

Endovascular flow direction indicator Download PDF

Info

Publication number
WO2011080738A1
WO2011080738A1 PCT/IL2010/001087 IL2010001087W WO2011080738A1 WO 2011080738 A1 WO2011080738 A1 WO 2011080738A1 IL 2010001087 W IL2010001087 W IL 2010001087W WO 2011080738 A1 WO2011080738 A1 WO 2011080738A1
Authority
WO
WIPO (PCT)
Prior art keywords
fin
delivery shaft
expanded state
rotation
shaft
Prior art date
Application number
PCT/IL2010/001087
Other languages
French (fr)
Inventor
Alon Shalev
Sagi Raz
Original Assignee
Endospan Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Endospan Ltd. filed Critical Endospan Ltd.
Priority to US13/519,971 priority Critical patent/US8956397B2/en
Priority to CA2785953A priority patent/CA2785953C/en
Priority to EP10840702.4A priority patent/EP2519166A4/en
Publication of WO2011080738A1 publication Critical patent/WO2011080738A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/95Instruments specially adapted for placement or removal of stents or stent-grafts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A61B17/12022Occluding by internal devices, e.g. balloons or releasable wires
    • A61B17/12099Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder
    • A61B17/12109Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder in a blood vessel
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A61B17/12022Occluding by internal devices, e.g. balloons or releasable wires
    • A61B17/12099Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder
    • A61B17/12109Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder in a blood vessel
    • A61B17/12113Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder in a blood vessel within an aneurysm
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A61B17/12022Occluding by internal devices, e.g. balloons or releasable wires
    • A61B17/12099Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder
    • A61B17/12109Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder in a blood vessel
    • A61B17/12113Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder in a blood vessel within an aneurysm
    • A61B17/12118Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder in a blood vessel within an aneurysm for positioning in conjunction with a stent
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A61B17/12022Occluding by internal devices, e.g. balloons or releasable wires
    • A61B17/12131Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device
    • A61B17/1214Coils or wires
    • A61B17/1215Coils or wires comprising additional materials, e.g. thrombogenic, having filaments, having fibers, being coated
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/01Filters implantable into blood vessels
    • A61F2/011Instruments for their placement or removal
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A61B17/12022Occluding by internal devices, e.g. balloons or releasable wires
    • A61B2017/1205Introduction devices
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B90/00Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
    • A61B90/08Accessories or related features not otherwise provided for
    • A61B2090/0807Indication means
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B90/00Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
    • A61B90/36Image-producing devices or illumination devices not otherwise provided for
    • A61B90/37Surgical systems with images on a monitor during operation
    • A61B2090/376Surgical systems with images on a monitor during operation using X-rays, e.g. fluoroscopy
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B90/00Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
    • A61B90/39Markers, e.g. radio-opaque or breast lesions markers
    • A61B2090/3966Radiopaque markers visible in an X-ray image

Definitions

  • This present application relates generally to surgical tools and methods, and specifically to endovascular surgical tools and techniques for implanting prostheses to maintain patency of body passages such as blood vessels, such as for treating aneurysms.
  • Endovascular prostheses are sometimes used to treat aortic aneurysms.
  • Such treatment includes implanting a stent or stent-graft within the diseased vessel to bypass the anomaly.
  • An aneurysm is a sac formed by the dilation of the wall of the artery. Aneurysms may be congenital, but are usually caused by disease or, occasionally, by trauma.
  • Aortic aneurysms which commonly form between the renal arteries and the iliac arteries are referred to as abdominal aortic aneurysms ("AAAs").
  • Other aneurysms occur in the aorta, such as thoracic aortic aneurysms ("TAAs") and aortic uni-iliac (“AUI”) aneurysms.
  • TAAs thoracic aortic aneurysms
  • AUI aortic uni-iliac
  • the endovascular tool useful for aligning an imaging system, in order to facilitate properly aligning an implantable medical device, such as a vascular stent.
  • the endovascular tool comprises a longitudinal delivery shaft and a fin coupled to the delivery shaft.
  • the fin is configured to assume a compressed state for endoluminal delivery, and an expanded state for endoluminal deployment, in which state the fin is configured to pivot around an axis of rotation.
  • the fin is configured such that, when the fin is placed in a blood flow path, at least a portion of the fin pivots in a direction that is indicative of a direction of blood flow in a vicinity of the fin.
  • the fin is endoluminally deployed in one or more blood vessels of a subject, such as in the left and right common iliac arteries in a vicinity of a bifurcation with the descending abdominal aorta.
  • the endovascular tool is endoluminally introduced into the one or more blood vessels while the fin is in its compressed state, typically in an outer shaft.
  • the outer shaft is withdrawn proximally, thereby delivering the fin from the outer shaft, and transitioning the fin to its expanded state.
  • the fin In its expanded state, the fin is configured to pivot around the axis of rotation, as described above.
  • a blood flow path such as blood flow downstream from the descending abdominal aorta into the iliac arteries
  • at least a portion of the fin pivots in a direction that is indicative of the direction of blood flow in the vicinity of the fin.
  • the tool is positioned such that the axis of rotation is generally perpendicular to the direction of blood flow in the vicinity of the axis of rotation.
  • a radiographic image (such as a fluoroscopy image) of the fin is generated using an imaging system.
  • the image is used to align an image plane of the imaging system generally parallel to a plane defined by the fin that is indicative of the direction of blood flow in the vicinity of the fin. This plane is defined by (a) the axis of rotation of the fin and (b) a vector oriented in the direction that the fin extends from the axis of rotation.
  • a spatial attitude of a component of the imaging system is changed (sometimes repeatedly), responsively to the radiographic image, until the image plane is generally parallel to the plane indicative of the direction of the blood flow in the vicinity of the fin.
  • the fin will appear with a modified aspect ratio in the image to the extent that the image plane is not parallel with the plane indicative of the direction of blood flow in the vicinity of the fin.
  • the spatial attitude of the component of the imaging system is adjusted until the fin appears to have its actual aspect ratio, indicating that the image plane and plane indicative of the direction of blood flow in the vicinity of the fin are parallel.
  • the spatial attitude of the component of the imaging system is adjusted until an apparent shape of the fin (either of the entire fin, or of a portion thereof, such as one or more radiographic markers thereof), as shown in the radiographic image, is no longer distorted (e.g., no longer has a modified aspect ratio) compared to an actual shape of the fin, (e.g., appears to have its actual aspect ratio).
  • the assessing and changing of the spatial attitude are repeated until a desired relationship has been obtained between the apparent dimensions and the actual dimensions of the fin.
  • the delivery shaft and the fin are withdrawn from the patient.
  • the fin is first transitioned back to its compressed state, by retracting the fin into the outer shaft, by either advancing the outer shaft distally, and/or withdrawing the delivery shaft proximally.
  • a medical device such as a stent (which, optionally, comprises a stent-graft), is introduced into vasculature of the subject, typically the one or more blood vessels from which the fin was withdrawn, or one or more other blood vessels in a vicinity of the one or more blood vessels from which the fin was withdrawn.
  • the medical device is oriented using one or more images generated by the imaging system. Because the imaging system is properly aligned, as described above, the medical device can be properly aligned using images generated by the imaging system.
  • the medical device e.g., the stent
  • the stent is rotationally oriented using the one or more images generated by the imaging system.
  • the stent may be shaped so as to define a lateral opening, and the lateral opening may be rotationally oriented using the imaging system, such as to face in a direction that is parallel to the image plane. If the imaging plane of the imaging system were not properly aligned as described above, the lateral opening would not be properly rotated to face the descending abdominal aorta, but instead would face another direction parallel to the misaligned imaging plane.
  • the imaging plane is sometimes misaligned with the plane indicative of the direction of blood flow by up to about 20 degrees, which results in the lateral opening being misaligned with the bifurcation with the descending abdominal aorta by up to about 20 degrees.
  • the fin comprises a structural member and at least one substantially flow-resistant membrane member, which is securely mounted to at least a portion of the structural member.
  • the fin is at least partially radiopaque, in order to facilitate radiographic imaging of the fin.
  • the fin extends laterally from a portion of the delivery shaft, and a longitudinal axis of the portion coincides with the axis of rotation of the fin.
  • the fin is shaped so as to define one or more pivot joints, which rotatably couple the fin to the portion of the delivery shaft.
  • the pivot joints are configured to facilitate at least 180 degrees of rotation of the fin around the delivery shaft, at least when the fin is in its expanded state.
  • the pivot joints and the delivery shaft are configured to facilitate low-friction rotation of the fin around the delivery shaft, at least when the fin is in its expanded state.
  • the fin has a substantially planar shape when in its expanded state.
  • the substantially planar shape may be a parallelogram, a rectangle, a square, a semicircle, a trapezoid, a shape defined by a curved segment having ends connected by a straight line, or a shape defined by an arc having ends connected by a straight line.
  • the endovascular tool is used to treat an aneurysm, such as an aortic aneurism, or an aneurism of another blood vessel.
  • an aneurysm such as an aortic aneurism, or an aneurism of another blood vessel.
  • the aneurism may be of the sub-renal aorta.
  • apparatus including an endovascular tool, which includes:
  • a fin which is coupled to the delivery shaft, and which is configured to assume (a) a compressed state for endoluminal delivery, and (b) an expanded state for endoluminal deployment, in which state the fin is configured to pivot around an axis of rotation.
  • the fin is configured such that, when the fin is placed in a blood flow path, at least a portion of the fin pivots in a direction that is indicative of a direction of blood flow in a vicinity of the fin.
  • the fin is pivotable to rotate at least 180 degrees around the axis of rotation, at least when the fin is in its expanded state.
  • the delivery shaft has a length of at least 10 cm.
  • the fin at least when in its expanded state, extends laterally from a portion of the delivery shaft, and a longitudinal axis of the portion coincides with the axis of rotation.
  • the longitudinal axis of the portion of the delivery shaft substantially lies within a plane generally defined by the fin when in its expanded state.
  • the fin includes a structural member and a substantially flow-resistant membrane member, which is securely mounted to at least a portion of the structural member, and the longitudinal axis of the portion of the delivery shaft substantially lies within a plane generally defined by the membrane member when the fin is in its expanded state.
  • the fin is shaped so as to define one or more pivot joints, which rotatably couple the fin to the portion of the delivery shaft.
  • each of the one or more pivot joints is shaped so as to surround at least 210 degrees of the delivery shaft.
  • the pivot joints are configured to facilitate at least 180 degrees of rotation of the fin around the delivery shaft, at least when the fin is in its expanded state.
  • the pivot joints and the delivery shaft are configured to facilitate low-friction rotation of the fin around the delivery shaft, at least when the fin is in its expanded state.
  • the pivot joints and the delivery shaft are configured to provide a coefficient of static friction between the pivot joints and the delivery shaft of no more than 0.5.
  • the pivot joints and the delivery shaft are configured such that the pivot joints rotate with respect to the delivery shaft even when the fin is positioned in a blood flow of a healthy peripheral artery having a diameter of at least 3 mm in a subject having a systolic to diastolic blood pressure gradient of at least 30 mmHg.
  • at least one of the pivot joints e.g., exactly one of the pivot joints, or two or more of the pivot joints
  • the fin includes a structural member and at least one substantially flow-resistant membrane member, which is securely mounted to at least a portion of the structural member, and the structural member is shaped so as to define the one or more pivot joints.
  • the fin includes a structural member and at least one substantially flow-resistant membrane member, which is securely mounted to at least a portion of the structural member, and the membrane member is shaped so as to define the one or more pivot joints.
  • the portion of the delivery shaft has first and second ends from which respective first and second portions of the fin extend in a same radial direction from the longitudinal axis.
  • the endovascular tool further includes a support structure, which is coupled to the delivery shaft, and the fin is coupled to the support structure, so as to be indirectly coupled to the delivery shaft.
  • the endovascular tool includes exactly one fin.
  • the fin is at least partially radiopaque.
  • the fin includes a structural member, and a plurality of radiopaque markers, which are fixed to the structural member, and which have a greater radiopacity per unit weight than that of the structural member.
  • the fin includes a structural member and at least one substantially flow-resistant membrane member, which is securely mounted to at least a portion of the structural member.
  • the structural member includes a super-elastic material, such as a super-elastic metal alloy, e.g., Nitinol.
  • the flow-resistant membrane member includes an implantable-grade polymer, such as polytetrafluoroethylene (PTFE), e.g., expanded polytetrafluoroethylene (ePTFE).
  • PTFE polytetrafluoroethylene
  • ePTFE expanded polytetrafluoroethylene
  • the polymer includes a polyester.
  • the at least one membrane member has a surface area of between 9 and 50 mm2 when the fin is in its expanded state.
  • a length of the delivery shaft is at least 10 times a greatest dimension of the fin measured in a direction parallel with the axis of rotation when the fin is in its expanded state.
  • the fin has a substantially planar shape when in its expanded state.
  • the substantially planar shape may be selected from the group of shapes consisting of: a parallelogram, a rectangle, a square, a semicircle, a trapezoid, a shape defined by a curved segment having ends connected by a straight line, and a shape defined by an arc having ends connected by a straight line.
  • the fin has an airfoil shape when in its expanded state.
  • the fin is generally cylindrical when in its expanded state.
  • the fin has a greatest length in a direction perpendicular to the axis of rotation, which greatest length is at least 200% greater when the fin is in its expanded state than when the fin is in its compressed state.
  • the fin has a greatest length in a direction perpendicular to the axis of rotation when the fin is in its expanded state, which greatest length is between 3 and 15 mm.
  • the fin has a greatest length in a direction perpendicular to the axis of rotation when the fin is in its compressed state, which greatest length is between 1.5 and 4 mm.
  • the fin is configured to assume the compressed state when constrained, and to assume the expanded state when relaxed.
  • an axial length of the fin along the axis of rotation is at least 50% greater when the fin is in its compressed state than when the fin is in its expanded state.
  • an axial length of the fin along the axis of rotation is between 6 and 20 mm when the fin is in its expanded state.
  • an axial length of the fin along the axis of rotation is between 10 and 40 mm when the fin is in its compressed state.
  • the apparatus may further include a generally tubular outer shaft, in which the delivery shaft is at least partially positioned, and in which the fin is initially positioned in its compressed state at least partially alongside the delivery shaft.
  • the outer shaft, the delivery shaft, and the fin are configured such that longitudinal translation of the outer shaft with respect to the delivery shaft (a) in a first axial direction effects a transition of the fin from its compressed state to its expanded state, and (b) in a second axial direction opposite the first axial direction effects a transition of the fin from its expanded state to its compressed state.
  • the outer shaft, the delivery shaft, and the fin are configured such that rotation of the outer shaft with respect to the delivery shaft (a) in a first rotational direction effects a transition of the fin from its compressed state to its expanded state, and (b) in a second rotation direction opposite the first rotation direction effects a transition of the fin from its expanded state to its compressed state.
  • the apparatus may further include an endovascular guidewire, and the delivery shaft is shaped so as to define a longitudinal bore therethrough, which is configured to allow deployment of the delivery shaft over the guidewire.
  • an endovascular tool including a longitudinal delivery shaft and a fin coupled to the delivery shaft;
  • the method further includes, after transitioning, generating a radiographic image of the fin using an imaging system.
  • the method further includes changing a spatial attitude of a component of the imaging system, responsively to the radiographic image, such that an image plane of the imaging system is generally parallel to a plane defined by the fin that is indicative of a direction of blood flow in a vicinity of the fin.
  • the method further includes changing a spatial attitude of a component of the imaging system until an apparent shape of the fin, as shown in the radiographic image, no longer has a modified aspect ratio compared to its actual aspect ratio.
  • the method further includes,, after generating the image, assessing one or more apparent dimensions of the fin as shown in the image.
  • assessing includes assessing two or more apparent dimensions of the fin, and assessing at least one ratio between two of the two or more apparent dimensions.
  • the method further includes, after generating the image, assessing a reference dimension of a portion of the delivery shaft, and comparing the one or more apparent dimensions of the fin with the reference dimension.
  • assessing includes measuring the one or more apparent dimensions.
  • the method further includes, further including, after assessing, comparing the one or more apparent dimensions with one or more respective actual dimensions of the fin in its expanded state.
  • assessing includes assessing two or more apparent dimensions of the fin
  • comparing includes comparing a ratio of two of the apparent dimensions with a ratio of two of the actual dimensions.
  • the method further includes changing a spatial attitude of a component of the imaging system responsively to the assessing.
  • changing includes changing the spatial attitude of the component such that an image plane of the imaging system is generally parallel to a plane defined by the fin that is indicative of a direction of blood flow in a vicinity of the fin.
  • assessing and changing the spatial attitude include repeatedly assessing and changing the spatial attitude until a desired relationship has been obtained between the apparent dimensions and the actual dimensions of the fin.
  • the imaging system is a fluoroscopy system
  • the component of the imaging system is a C-arm
  • changing the spatial attitude includes changing the spatial attitude of the C-arm.
  • the method further includes, after changing the spatial attitude:
  • orienting include rotationally orienting the medical device.
  • the medical device is a stent, and introducing and orienting includes introducing and orienting the stent.
  • the stent is shaped so as to define a lateral opening, and orienting the stent includes orienting the lateral opening.
  • orienting the lateral opening includes orienting the lateral opening to face in a direction that is parallel to the image plane.
  • the stent includes two or more radiopaque features distributed around the lateral opening, and orienting the lateral opening includes orienting the lateral opening such that at least a portion of the radiopaque features are aligned with one another in the one or more images.
  • endoluminally introducing the endovascular tool includes endoluminally introducing a guidewire into the one or more blood vessels, and advancing the delivery shaft over the guidewire such that the guidewire passes through the bore,
  • withdrawing the endovascular tool includes leaving the guidewire in the one or more blood vessels, and
  • introducing the medical device includes introducing the medical device over the guidewire.
  • endoluminally introducing includes positioning the fin in a vicinity of a bifurcation between at least two blood vessels.
  • endoluminally introducing includes positioning the delivery shaft in the one or more blood vessels such that the fin is aligned with the bifurcation.
  • positioning the delivery shaft includes positioning two portions of the delivery shaft in left and right common iliac arteries, respectively.
  • the method further includes identifying that the patient suffers from an aneurysm, and endoluminally introducing includes endoluminally introducing the endovascular tool responsively to the identifying.
  • transitioning includes transitioning the fin to its expanded state in which the fin extends laterally from a portion of the delivery shaft, and a longitudinal axis of the portion coincides with the axis of rotation.
  • providing the endovascular tool includes providing the endovascular tool in which the fin is shaped so as to define one or more pivot joints, which rotatably couple the fin to the portion of the delivery shaft.
  • providing the endovascular tool includes providing the endovascular tool further including a support structure, which is coupled to the delivery shaft, and the fin is coupled to the support structure, so as to be indirectly coupled to the delivery shaft.
  • providing the endovascular tool includes providing the endovascular tool including exactly one fin.
  • providing the endovascular tool includes providing the endovascular tool in which the fin is at least partially radiopaque.
  • providing the endovascular tool includes providing the endovascular tool in which the fin includes a structural member and at least one substantially flow-resistant membrane member, which is securely mounted to at least a portion of the structural member.
  • transitioning includes transitioning the fin to its expanded in which state the fin has a substantially planar shape.
  • the substantially planar shape may be selected from the group of shapes consisting of: a parallelogram, a rectangle, a square, a semicircle, a trapezoid, a shape defined by a curved segment having ends connected by a straight line, and a shape defined by an arc having ends connected by a straight line.
  • providing the endovascular tool includes providing the endovascular tool further including a generally tubular outer shaft, and endoluminally introducing includes endoluminally introducing the outer shaft in which the delivery shaft is at least partially positioned, and in which the fin is initially positioned in its compressed state at least partially alongside the delivery shaft.
  • transitioning the fin to its expanded state includes longitudinally translating the outer shaft with respect to the delivery shaft in a first axial direction, and further including subsequently longitudinally translating the outer shaft with respect to the delivery shaft in a second axial direction opposite the first axial direction to effect a transition of the fin from its expanded state to its compressed state.
  • transitioning the fin to its expanded state includes rotating the outer shaft with respect to the delivery shaft in a first axial direction, and further including subsequently rotating the outer shaft with respect to the delivery shaft in a second axial direction opposite the first axial direction to effect a transition of the fin from its expanded state to its compressed state.
  • FIGs. 1A-C are schematic illustrations of an endovascular tool in compressed, partially-expanded, and expanded states, respectively, in accordance with an application of the present invention
  • FIGS. 2A-B are schematic illustrations of another configuration of the endovascular tool of Figs. 1 A-C in compressed and expanded states, respectively, in accordance with an application of the present invention
  • FIG. 3 is a schematic illustration of yet another configuration of the endovascular tool of Figs. 1A-C in an expanded state, in accordance with an application of the present invention
  • Fig. 4 is a schematic illustration of still another configuration of the endovascular tool of Figs. 1A-C in an expanded state, in accordance with an application of the present invention
  • Fig. 5 is a schematic illustration of another configuration of the endovascular tool of Figs. 1A-C in an expanded state, in accordance with an application of the present invention
  • Fig. 6 is a schematic illustration of yet another configuration of the endovascular tool of Figs. 1A-C in an expanded state, in accordance with an application of the present invention
  • Fig. 7 is a schematic illustration of another configuration of the endovascular tool of Figs. 1A-C in an expanded state, in accordance with an application of the present invention
  • Fig. 8 is a schematic illustration of yet another configuration of the endovascular tool of Figs. 1A-C in an expanded state, in accordance with an application of the present invention
  • Figs. 9A-C are schematic illustrations of respective configurations of the endovascular tool of Figs. 1A-C in an expanded state, in accordance with respective applications of the present invention
  • Figs. 10A-F are schematic illustrations of an exemplary transluminal procedure performed using the endovascular tool of Figs. 1A-C, in accordance with an application of the present invention.
  • FIGs. 1A-C are schematic illustrations of an endovascular tool 10 in compressed, partially-expanded, and expanded states, respectively, in accordance with an application of the present invention.
  • Endovascular tool 10 typically comprises a longitudinal delivery shaft 24 and a fin 20 coupled to the delivery shaft.
  • the fin is configured to assume (a) a compressed state for endoluminal delivery (and, optionally, retrieval), as shown in Fig. 1A, and (b) an expanded state for endoluminal deployment, in which state the fin is configured to pivot around an axis of rotation 18, such as shown in Fig. 1C.
  • Fin 20 typically assumes its compressed state when positioned a generally tubular outer shaft 22 at least partially alongside delivery shaft 24, initially before deployment of the fin, as described hereinbelow with reference to Fig.
  • Fig. IB shows the fin in an intermediate, partially-expanded state, in which the fin is partially deployed from outer shaft 22.
  • tool 10 comprises exactly one fin 20; alternatively, tool 10 comprises two or more fins (configuration not shown).
  • fin 20 is relaxed in its expanded state.
  • the fin is configured to be self-expanding.
  • the fin may be heat- set to assume its expanded state.
  • fin 20 is configured to assume the compressed state when constrained (such as when within outer shaft 22), and to assume the expanded state when relaxed.
  • fin 20 is configured such that, when the fin is placed in a blood flow path, at least a portion of the fin pivots in a direction that is indicative of the direction of blood flow in a vicinity of the fin.
  • fin 20 is pivotable to rotate at least 180 degrees around axis of rotation 18, as schematically indicated by an arrow 26 in Fig. 1C, at least when the fin is in its expanded state.
  • fin 20 comprises a structural member 32 and at least one substantially flow-resistant membrane member 34, which is securely mounted to at least a portion of the structural member, either directly or indirectly, such as by a plurality of coupling elements 36, e.g., sutures or threads.
  • structural member 32 comprises a super-elastic material, such as a super-elastic metal alloy, e.g., Nitinol.
  • Membrane member 34 typically comprises a thin pliable sheet of material, which may, for example, comprise an implantable-grade polymer, such as polytetrafluoroethylene (PTFE), e.g., expanded polytetrafluoroethylene (ePTFE), a polyester, or a textile material (e.g., polyethylene terephthalate (PET)).
  • PTFE polytetrafluoroethylene
  • ePTFE expanded polytetrafluoroethylene
  • PET polyethylene terephthalate
  • membrane member 34 has a surface area of at least 9 mm2, no more than 50 mm2, and/or between 9 and 50 mm2.
  • fin 20 extends laterally from a portion 28 of delivery shaft 24, and a longitudinal axis of portion 28 coincides with axis of rotation 18.
  • the longitudinal axis of portion 28 typically substantially lies within a plane 29 generally defined by fin 20 and/or membrane member 34 when the fin is in its expanded state, as shown in the side-view blow-up in Fig. 1C.
  • portion 28 has first and second ends from which respective first and second portions of fin 20 extend in a same radial direction from longitudinal axis 18, for example, the direction indicated by a vector V in Fig. 1C.
  • axis of rotation 18 does not coincide with a longitudinal axis of delivery shaft 24.
  • fin 20 (typically, structural member 32 and/or membrane member 34) is shaped so as to define one or more pivot joints 38, which rotatably couple the fin to portion 28 of delivery shaft 24.
  • the pivot joints may include exactly two pivot joints 38A and 38B, such as shown in Figs. 1A-C (and Figs. 3-6, described hereinbelow).
  • exactly one pivot joint may be provided, such as shown in Fig. 8, or more than two pivot joints may be provided, such as shown in Figs. 2A-B, described hereinbelow.
  • each of pivot joints 38 is shaped so as to surround at least 210 degrees of delivery shaft 24, such as at least 270 degrees, or 360 degrees (i.e., entirely surround the shaft), in order to be coupled to the delivery shaft.
  • pivot joints 38 are configured to facilitate at least 180 degrees of rotation of the fin around the delivery shaft, as indicated by arrow 26 in Fig. 1C, at least when the fin is in its expanded state.
  • pivot joints 38 and delivery shaft 24 are configured to facilitate low- friction rotation of fin 20 around the delivery shaft, at least when the fin is in its expanded state.
  • the pivot joints and the delivery shaft may be configured to provide a coefficient of static friction between the pivots and the delivery shaft of no more than 0.5, such as no more than 0.2.
  • the pivot joints and the delivery shaft may be configured such that the pivot joints rotate with respect to the delivery shaft even when fin 20 is positioned in a blood flow of a healthy peripheral artery having a diameter of at least 3 mm in a subject having a systolic to diastolic blood pressure gradient of at least 30 mmHg.
  • At least one (e.g., exactly one, or two or more) of pivot joints 38 is axially fixed to delivery shaft 24 so as to prevent axial motion of the at least one of the pivots with respect to the delivery shaft.
  • fixation may aid in deployment of fin 20 from outer shaft 22, such as described hereinbelow with reference to Fig. IOC.
  • fin 20 has a substantially planar shape when in its expanded state.
  • the substantially planar shape may be a parallelogram, a rectangle (such as shown in Figs. 2B, 3, and 4), a square, a semicircle, a trapezoid, a shape defined by a curved segment having ends connected by a straight line (such as shown Figs. 1C and 6), or a shape defined by an arc having ends connected by a straight line.
  • fin 20 has an airfoil shape (e.g., a symmetrical airfoil) when in its expanded state (configuration not shown).
  • fin 20 is generally cylindrical when in its expanded state, such as described hereinbelow with reference to Fig. 8.
  • a length of delivery shaft 24 is at least 10 times, such as at least 20 times a greatest dimension Dl of fin 20 measured in a direction parallel with axis of rotation 18, when the fin is in its expanded state, as shown in Fig. 1C.
  • greatest dimension Dl is at least 3 mm, no more than 30 mm, and or between 3 and 30 mm.
  • a greatest dimension D2 of fin 20 measured in a direction parallel with axis of rotation 18, when the fin is in its compressed state is at least 5 mm, no more than 50 mm, and/or between 5 and 50 mm, as shown in Fig. 1A.
  • delivery shaft 24 has a length of at least 10 cm, such as at least 50 cm.
  • fin 20 has a greatest length LI in a direction perpendicular to axis of rotation 24 when the fin is in its expanded state, which greatest length is at least 3 mm, no more than 15 mm, and/or between 3 and 15 mm, as shown in Fig. 1C.
  • fin 20 has a greatest length L2 in a direction perpendicular to axis of rotation 24 when the fin is in its compressed state, which greatest length is at least 1.5 mm, no more than 4 mm, and/or between 1.5 and 4 mm, as shown in Fig. 1A.
  • greatest length LI when the fin is in its expanded state
  • greatest length L2 is at least 200% greater than greatest length L2 (when the fin is in its compressed state).
  • an axial length L3 of fin 20 along axis of rotation 18 is at least 6 mm, no more than 20 mm, and/or between 6 and 20 mm when the fin is in its expanded state, as shown in Fig. 1C.
  • greatest dimension Dl may be greater than axial length L3, when the greatest dimension does not coincide with axis of rotation 18.
  • an axial length L4 of fin 20 along axis of rotation 18 is at least 10 mm, no more than 40 mm, and/or between 10 and 40 mm when the fin is in its compressed state, as shown in Fig. 1A.
  • axial length L4 (when the fin is in its compressed state) is at least 50% greater than axial length L3 (when the fin is in its expanded state).
  • outer shaft 22, delivery shaft 24, and fin 20 are configured such that longitudinal translation of the outer shaft with respect to the delivery shaft (a) in a first axial direction (e.g., translation of the outer shaft to the left in Figs. 1A-C) effects a transition of the fin from its compressed state (such shown in Fig. 1A) to its expanded state (such as shown in Fig. 1C), and (b) in a second axial direction opposite the first axial direction effects a transition of the fin from its expanded state to its compressed state.
  • the fin is configured to be capable of being compressed by the outer shaft when withdrawn into the outer shaft.
  • outer shaft 22, delivery shaft 24, and fin 20 are configured such that rotation of the outer shaft with respect to the delivery shaft (a) in a first rotational direction effects a transition of the fin from its compressed state to its expanded state, and (b) in a second rotation direction opposite the first rotation direction effects a transition of the fin from its expanded state to its compressed state.
  • outer shaft 22 and delivery shaft 24 may be shaped so as to define a threading therebetween.
  • an endovascular guidewire 30 is provided.
  • Delivery shaft 24 is shaped so as to define a longitudinal bore therethrough, which is configured to allow deployment of the delivery shaft over the guidewire.
  • FIGs. 2A-B are schematic illustrations of another configuration of endo vascular tool 10 in compressed and expanded states, respectively, in accordance with an application of the present invention. Except as described below, this configuration of tool 10 is generally similar to the configuration described hereinabove with reference to Figs. 1A-C.
  • fin 20 (typically, structural member 32 and/or membrane member 34) is shaped so as to define three pivot joints 38, which rotatably couple the fin to portion 28 of delivery shaft 24.
  • First and second ones of these pivot joints (38A and 38B) extend to respective axial ends of portion 28 of dehvery shaft 24, and a third one of the pivot joints (38C) is positioned between first and second pivot joints 38A and 38B.
  • structural member 32 is shaped so as to define all three pivot joints 38A, 38B, and 38C.
  • pivot joint 38C is not directly coupled to the remainder of structural member 32.
  • membrane member 34 is coupled to the portion of structural member 32 that defines pivot joint 38C (such as by coupling elements 36), as well as to the portion of structural member 32 that defines pivot joints 38A and 38B.
  • fin 20 is shown in Fig. 2B as having the shape of a rectangle when in its expanded state, the fin may alternatively have another shapes, such as the shapes described hereinabove with reference to Figs. 1A-C, and or shown in any of the other figures.
  • One or more of the features of the configuration of fin 20 described with referenced to and/or shown in Figs. 2A-B may be implemented in combination with the features of fin 20 described with reference to and/or shown in Figs. 1A-C, 3, 4, 5, 6, 7, 8, and/or 9A-C.
  • FIG. 3 is a schematic illustration of yet another configuration of endo vascular tool 10 in an expanded state, in accordance with an application of the present invention.
  • This configuration of tool 10 is generally similar to the configuration described hereinabove with reference to Figs. 2A-B, except that fin 20 comprises only first and second pivot joints 38A and 38B, and not third pivot joint 38C.
  • One or more of the features of the configuration of fin 20 described with referenced to and or shown in Fig. 3 may be implemented in combination with the features of fin 20 described with reference to and/or shown in Figs. 1A-C, 2A-B, 4, 5, 6, 7, 8, and/or 9A-C.
  • FIG. 4 is a schematic illustration of still another configuration of endovascular tool 10 in an expanded state, in accordance with an application of the present invention. Except as described hereinbelow with reference to Figs. 1A-C and 2-7, this configuration of tool 10 is generally similar to the configuration described hereinabove with reference to Fig. 3.
  • One or more of the features of the configuration of fin 20 described with referenced to and/or shown in Fig. 4 may be implemented in combination with the features of fin 20 described with reference to and/or shown in Figs. 1A-C, 2A-B, 3, 5, 6, 7, 8, and/or 9A-C.
  • Fig. 5 is a schematic illustration of another configuration of endovascular tool 10 in an expanded state, in accordance with an application of the present invention. Except as described below, this configuration of tool 10 is generally similar to the configuration described hereinabove with reference to Fig. 4.
  • structural member 32 is shaped so as to define one or more loops 42. These loops may serve to reduce kinking in at least one corner of the structural member, when the fin is folded into outer shaft 22.
  • One or more of the features of the configuration of fin 20 described with referenced to and/or shown in Fig. 5 may be implemented in combination with the features of fin 20 described with reference to and/or shown in Figs. 1A-C, 2A-B, 3, 4, 6, 7, 8, and/or 9A-C.
  • FIG. 6 is a schematic illustration of yet another configuration of endovascular tool 10 in an expanded state, in accordance with an application of the present invention. Except as described below, this configuration of tool 10 is generally similar to the configuration described hereinabove with reference to Figs. 1A-C. In this configuration pivot joints 38A and 38B come nearly in contact with each other along delivery shaft 24 when the fin is in its expanded state, such as within 2 mm of each other.
  • One or more of the features of the configuration of fin 20 described with referenced to and/or shown in Fig. 6 may be implemented in combination with the features of fin 20 described with reference to and/or shown in Figs. 1A-C, 2A-B, 3, 4, 5, 7, 8, and/or 9A-C.
  • FIG. 7 is a schematic illustration of another configuration of endo vascular tool 10 in an expanded state, in accordance with an application of the present invention. Except as described below, this configuration of tool 10 is generally similar to the configuration described hereinabove with reference to Figs. 1A-C.
  • endo vascular tool 10 further comprises a support structure 50, which is coupled to delivery shaft 24.
  • support structure 50 is rotationally fixed with respect to the delivery shaft and/or axially-fixed to the delivery shaft to prevent axial motion of the support structure with respect to the shaft.
  • the support structure is only axially fixed to the shaft, only rotationally fixed to the shaft, or neither axially fixed nor rotationally fixed to the shaft.
  • Fin 20 is coupled to support structure 50, so as to be indirectly coupled to delivery shaft 24.
  • Fin 20 is configured to pivot around axis of rotation 18, which, in this configuration, does not coincide with the longitudinal axis of portion 28 of delivery shaft 24.
  • axis of rotation 18 coincides with an axis of a portion of support structure 50, such as shown in Fig. 7.
  • axis of rotation 18 is generally parallel with the longitudinal axis of portion 28 of delivery shaft 24, such as shown in Fig.
  • the axis of rotation is not generally parallel with the longitudinal axis of portion 28 (configuration not shown).
  • One or more of the features of the configuration of fin 20 described with referenced to and/or shown in Fig. 7 may be implemented in combination with the features of fin 20 described with reference to and/or shown in Figs. 1A-C, 2A-B, 3, 4, 5,
  • Figs. 1A-C and 2-7 respective portions of structural member 32 that define pivot joints 38A and 38B have respective ends 44.
  • ends 44 face in axially-opposite directions along axis of rotation 18.
  • ends 44 face axially toward each other along axis of rotation 18, while for others of these applications, such as shown in Figs. 2A-B and 3, ends 44 face axially away from each other along axis of rotation 18 (this configuration may facilitate retraction of the fin into outer shaft 22).
  • ends 44 face in the same axial direction along axis of rotation 18.
  • Fig. 8 is a schematic illustration of yet another configuration of endo vascular tool 10 in an expanded state, in accordance with an application of the present invention.
  • fin 20 is generally cylindrical when in its expanded state.
  • a central axis of the fin 20 is generally parallel to axis of rotation 18, as shown in Fig. 8, while for other applications, the central axis of the fin is generally perpendicular to the axis of rotation (configuration not shown).
  • Figs. 9A-C are schematic illustrations of respective configurations of endo vascular tool 10 in an expanded state, in accordance with respective applications of the present invention.
  • fin 20 is at least partially radiopaque, in order to facilitate radiographic imaging of the fin, such as described hereinbelow with reference to Fig. 10D.
  • fin 20 comprises a plurality of radiopaque markers 40, which are fixed to structural member 40, and have a greater radiopacity per unit weight than that of the structural member.
  • at least some of radiopaque markers 40 comprise small circular or semispherical elements, such as shown in Fig. 9A.
  • at least some of radiopaque markers 40 comprise short tube segment, as shown in Figs.
  • radiopaque markers 40 are fixed to membrane member 34 (configuration not shown).
  • Figs. 9A-C illustrate radiopaque markers 40 applied to the configuration of fin 20 described hereinabove with reference to Figs. 1A-C, the radiopaque markers may be similarly applied to the other configurations of fin 20 described herein, such as with reference to Figs. 2A-B, 3, 4, 5, 6, 7, and/or 8.
  • Figs. 10A-F are schematic illustrations of an exemplary transluminal procedure performed using endo vascular tool 10, in accordance with an application of the present invention. Although this procedure is illustrated using the configuration of tool 10 described hereinabove with reference to Figs. 1A-C, the procedure may also be used to deploy the other configurations of tool 10 described herein, mutatis mutandis.
  • the exemplary procedures begins by endoluminally introducing guidewire 30 into one or more blood vessels of a subject.
  • fin 20 may be positioned in a vicinity of a bifurcation between at least two blood vessels, optionally aligned with the bifurcation, as shown in Fig. 10A.
  • the guidewire is shown introduced into left and right common iliac arteries 100A and 100B.
  • endovascular tool 10 is endoluminally introduced into the one or more blood vessels while fin 20 is in its compressed state.
  • delivery shaft 24 is passed over guidewire 30 such that the guidewire passes through a bore defined by the delivery shaft, and outer shaft 22 is also passed over the guidewire.
  • Fin 20 is initially positioned in its compressed state within outer shaft 22, typically near a distal end of the outer shaft.
  • delivery shaft 24 is shown by way of illustration in Fig. 10B as extending slightly distally out of the distal end of outer shaft 22, delivery shaft 24 does not necessarily extend out of outer shaft 22 at this stage of deployment.
  • Delivery shaft 24 and outer shaft 22 are longitudinally translated with respect to each other, thereby delivering fin 20 from the outer shaft, and transitioning fin 20 to its expanded state, as shown in Fig. IOC.
  • this relative longitudinal translation is effected by holding delivery shaft 24 in place as outer shaft 22 is withdrawn proximally.
  • this relative longitudinal translation is effected by holding outer shaft 22 in place as delivery shaft 24 is advanced distally (technique not shown).
  • at least one (e.g., exactly one, or two or more) of pivot joints 38 is axially fixed to delivery shaft 24 so as to prevent axial motion of the at least one of the pivots with respect to the delivery shaft.
  • fixation may aid in deployment of the fin from outer shaft 22, by preventing fin 20 from moving with respect to outer shaft 22 as the delivery shaft and outer shaft are longitudinally translated with respect to each other.
  • the fin In its expanded state, the fin is configured to pivot around the axis of rotation, as described hereinabove with reference to Figs. 1A-C.
  • a blood flow path in this exemplary case, blood flow downstream from a descending abdominal aorta 102 into iliac arteries 100A and 100B
  • at least a portion of the fin pivots in a direction that is indicative of the direction of blood flow in the vicinity of the fin, as indicated by a vector V in Fig. IOC, perhaps best seen in Section A--A thereof.
  • Tool 10 is positioned such that axis of rotation 18 (and, in the illustrated configuration, portion 28 of delivery shaft 24) is generally perpendicular to the direction of blood flow, in the vicinity of the axis of rotation.
  • a radiographic image (such as a fluoroscopy image) of fin 20 is generated using an imaging system 120 (such as a fluoroscopy imaging system).
  • the image is used to align an image plane of imaging system 120 generally parallel to a plane 122 defined by the fin that is indicative of the direction of blood flow in the vicinity of the fin.
  • Plane 122 is defined by (a) axis of rotation 18 (and, in the illustrated configuration, portion 28 of delivery shaft 24), and (b) vector V oriented in the direction that fin 20 extends from axis of rotation 18.
  • image plane as used herein, including in the claims, is a plane that is perpendicular to the optical axis at any axial image point of the imaging system.
  • a spatial attitude i.e., an orientation or angular position
  • a component of the imaging system such as a C-arm 124
  • fin 20 in order to align the image plane, after generating the image, one or more apparent dimensions of fin 20 as shown in the image are assessed, and the spatial attitude of the component of the imaging system is changed responsively to the assessing.
  • fin 20 (optionally, as represented by radiopaque markers 40) will appear distorted in the image to the extent that the image plane is not parallel with plane 122.
  • the spatial attitude of the component of the imaging system is adjusted until fin 20 no longer appears distorted, indicating that the image plane and plane 122 are parallel.
  • the spatial attitude of the component of the imaging system is adjusted until an apparent shape of the fin (either of the entire fin, or of a portion thereof, such as one or more radiographic markers thereof), as shown in the radiographic image, is no longer distorted compared to an actual shape of the fin, i.e., no longer has a modified aspect ratio compared to its actual aspect ratio.
  • the assessing and changing of the spatial attitude are repeated until a desired relationship has been obtained between the apparent dimensions and the actual dimensions of the fin.
  • two or more apparent dimensions of the fin may be assessed, and at least one ratio between two of the two or more apparent dimensions may be assessed.
  • a reference dimension of a portion of the delivery shaft may be assessed, and the one or more apparent dimensions of the fin are compared with the reference dimension.
  • the dimensions of the fin may include one or more of the following: one or more distances between respective sets of two features of the fin (e.g., radiopaque markers 40), a greatest width of the fin in a direction parallel with axis of rotation 24, and/or a greatest length of the fin in a direction perpendicular to axis of rotation 24.
  • assessing comprises measuring the one or more apparent dimensions.
  • the one or more apparent dimensions are compared with one or more respective actual dimensions of the fin in its expanded state.
  • two or more apparent dimensions of the fin are assessed, and a ratio of two of the apparent dimensions are compared with a ratio of two of the actual dimensions.
  • delivery shaft 24 and fin 20 are withdrawn from the patient.
  • fin 20 is first retracted into outer shaft 22, by either advancing outer shaft 22 distally, or withdrawing delivery shaft 24 proximally, until the fin reassumes its contracted state.
  • a medical device such as a stent 106 (which, optionally, comprises a stent-graft), is introduced into vasculature of the subject, typically the one or more blood vessels from which the fin was withdrawn, or one or more other blood vessels in a vicinity of the one or more blood vessels from which the fin was withdrawn.
  • the medical device is oriented using one or more images generated by the imaging system. Because the imaging system is properly aligned, as described above, the medical device can be properly aligned, for example, specifically in the rotational dimension, using images generated by the imaging system.
  • the medical device e.g., stent 106
  • the stent is rotationally oriented using the one or more images generated by the imaging system.
  • the stent may be shaped so as to define a lateral opening 123, and the lateral opening may be rotationally oriented using the imaging system, such as to face in a direction that is parallel to the image plane.
  • lateral opening 123 is oriented to face the opening between descending abdominal aorta 102 and left and right common iliac arteries 100A and 100B. If the imaging plane of imaging system 120 were not properly aligned as described above, the lateral opening would not be properly rotated to face the descending abdominal aorta, but instead would face another direction parallel to the misaligned imaging plane.
  • stent 106 includes two or more radiopaque features 124 distributed around lateral opening 123.
  • lateral opening 123 is oriented such that at least a portion of radiopaque features 124 are aligned with one another in the one or more images.
  • stent 106 may be properly rotationally aligned when radiopaque feature 124A appears to coincide with radiopaque feature 124B in the two-dimensional radiographic image (because radiopaque feature 124A is directly above radiopaque feature 124B when viewed in the properly- aligned image plane), and radiopaque feature 124D appears to coincide with radiopaque feature 124C.
  • the medical device e.g., stent 106
  • a delivery shaft 130 as shown in Fig. 10E.
  • the medical device is typically aligned while still compressed in the delivery shaft, which is generally readily rotated in the vasculature.
  • guidewire 30 is left in the one or more blood vessels, and the medical device is introduced over the guidewire.
  • the medical device e.g., stent 106
  • the medical device is delivered from the delivery shaft, and transitions to a radially-expanded state. If necessary for precise alignment, the medical device typically can be further slightly rotated even after expansion thereof.
  • stent 106 may be configured using techniques described in US Patent Application Publication 2010/0063575, which is incorporated herein by reference, such as regarding stent graft component 60 thereof.
  • the techniques described herein are used for rotationally aligning stent graft component 60 of the '575 publication, optionally in combination with other apparatus and or methods described in the '575 publication.
  • additional stents e.g., stent-grafts
  • stent-grafts are deployed in combination with stent 106, either before or after deploying stent 106, such as using techniques described in one or more of the patent applications incorporated hereinbelow by reference.
  • a kit comprising endovascular tool 10 and at least one medical device, such as a stent (e.g., a stent-graft).
  • the kit further comprises delivery shaft 130 and/or guidewire 30.
  • endo vascular tool 10 is used to treat an aneurysm 104, such as an aortic aneurism, or an aneurism of another blood vessel.
  • the aneurism may be of the sub-renal aorta, as shown in Figs. 10A-F.
  • a method comprises identifying that a patient suffers from an aneurysm, such as an aortic aneurism (e.g., a sub-renal aortic aneurism), and, responsively to the identifying, endoluminally introducing endovascular tool 10 responsively to the identifying, and, optionally, a medical device, such as a stent, e.g., a stent-graft.
  • an aneurysm such as an aortic aneurism (e.g., a sub-renal aortic aneurism)
  • endoluminally introducing endovascular tool 10 responsively to the identifying, and, optionally, a medical device, such as a stent, e.g., a stent-graft.
  • endovascular tool 10 has sometimes been described hereinabove as being deployed in the common iliac arteries in a vicinity of a bifurcation with the descending abdominal aorta
  • the endovascular tool may, for some applications, also be deployed in other body lumens, such as at other branching body lumens.
  • the tool may be deployed in the aortic arch in a vicinity of one of the branches of the aortic arch, and also when placing a fenestrated stent between the common carotid artery and either the internal or external carotid artery, and an additional stent between the fenestration of the aforementioned stent and the other carotid artery.

Abstract

An endovascular tool (10) is provided, which includes a longitudinal delivery shaft (24) and a fin (20) coupled to the delivery shaft (24). The fin (20) is configured to assume (a) a compressed state for endoluminal delivery, and (b) an expanded state for endoluminal deployment, in which state the fin (20) is configured to pivot around an axis of rotation (18). Other embodiments are also described.

Description

ENDOVASCULAR FLOW DIRECTION INDICATOR
CROSS-REFERENCE TO RELATED APPLICATIONS
The present patent application claims priority from US Provisional Application 61/291,427, filed December 31, 2009, entitled, "Endovascular flow direction indicator and methods for using such," which is incorporated herein by reference.
FIELD OF THE APPLICATION
This present application relates generally to surgical tools and methods, and specifically to endovascular surgical tools and techniques for implanting prostheses to maintain patency of body passages such as blood vessels, such as for treating aneurysms. BACKGROUND OF THE APPLICATION
Endovascular prostheses are sometimes used to treat aortic aneurysms. Such treatment includes implanting a stent or stent-graft within the diseased vessel to bypass the anomaly. An aneurysm is a sac formed by the dilation of the wall of the artery. Aneurysms may be congenital, but are usually caused by disease or, occasionally, by trauma. Aortic aneurysms which commonly form between the renal arteries and the iliac arteries are referred to as abdominal aortic aneurysms ("AAAs"). Other aneurysms occur in the aorta, such as thoracic aortic aneurysms ("TAAs") and aortic uni-iliac ("AUI") aneurysms.
PCT Publication WO 2008/107885 to Shalev et al., and US Patent Application Publication 2010/0063575 to Shalev et al. in the US national stage thereof, which are incorporated herein by reference, describe a multiple-component expandable endoluminal system for treating a lesion at a bifurcation, including a self expandable tubular root member having a side-looking engagement aperture, and a self expandable tubular trunk member comprising a substantially blood impervious polymeric liner secured therealong. Both have a radially-compressed state adapted for percutaneous intraluminal delivery and a radially-expanded state adapted for endoluminal support.
The following references may be of interest:
US Patent 4,938,740 to Melbin
US Patent 5,824,040 to Cox et al. US Patent 7,044,962 to Elliott
US Patent 7,544,160 to Gross
US Patent Application Publication 2006/0229709 to Morris et al.
US Patent Application Publication 2006/0241740 to Vardi et al.
US Patent Application Publication 2008/0109066 to Quinn
PCT Publication WO 09/118733 to Karasik
PCT Publication WO 10/031060 to Tuval et al.
SUMMARY OF APPLICATIONS
Some applications of the present invention provide an endovascular tool useful for aligning an imaging system, in order to facilitate properly aligning an implantable medical device, such as a vascular stent. The endovascular tool comprises a longitudinal delivery shaft and a fin coupled to the delivery shaft. The fin is configured to assume a compressed state for endoluminal delivery, and an expanded state for endoluminal deployment, in which state the fin is configured to pivot around an axis of rotation. The fin is configured such that, when the fin is placed in a blood flow path, at least a portion of the fin pivots in a direction that is indicative of a direction of blood flow in a vicinity of the fin.
For some applications, the fin is endoluminally deployed in one or more blood vessels of a subject, such as in the left and right common iliac arteries in a vicinity of a bifurcation with the descending abdominal aorta. The endovascular tool is endoluminally introduced into the one or more blood vessels while the fin is in its compressed state, typically in an outer shaft. The outer shaft is withdrawn proximally, thereby delivering the fin from the outer shaft, and transitioning the fin to its expanded state.
In its expanded state, the fin is configured to pivot around the axis of rotation, as described above. When the fin is thus placed in a blood flow path (such as blood flow downstream from the descending abdominal aorta into the iliac arteries), at least a portion of the fin pivots in a direction that is indicative of the direction of blood flow in the vicinity of the fin. The tool is positioned such that the axis of rotation is generally perpendicular to the direction of blood flow in the vicinity of the axis of rotation.
A radiographic image (such as a fluoroscopy image) of the fin is generated using an imaging system. The image is used to align an image plane of the imaging system generally parallel to a plane defined by the fin that is indicative of the direction of blood flow in the vicinity of the fin. This plane is defined by (a) the axis of rotation of the fin and (b) a vector oriented in the direction that the fin extends from the axis of rotation.
In order to align the image plane of the imaging system, a spatial attitude of a component of the imaging system (such as a C-arm) is changed (sometimes repeatedly), responsively to the radiographic image, until the image plane is generally parallel to the plane indicative of the direction of the blood flow in the vicinity of the fin.
For some applications, in order to align the image plane, after generating the image, one or more apparent dimensions of the fin as shown in the image are assessed, and the spatial attitude of the component of the imaging system is changed responsively to the assessing. In general, the fin will appear with a modified aspect ratio in the image to the extent that the image plane is not parallel with the plane indicative of the direction of blood flow in the vicinity of the fin. The spatial attitude of the component of the imaging system is adjusted until the fin appears to have its actual aspect ratio, indicating that the image plane and plane indicative of the direction of blood flow in the vicinity of the fin are parallel. In other words, the spatial attitude of the component of the imaging system is adjusted until an apparent shape of the fin (either of the entire fin, or of a portion thereof, such as one or more radiographic markers thereof), as shown in the radiographic image, is no longer distorted (e.g., no longer has a modified aspect ratio) compared to an actual shape of the fin, (e.g., appears to have its actual aspect ratio). Typically, the assessing and changing of the spatial attitude are repeated until a desired relationship has been obtained between the apparent dimensions and the actual dimensions of the fin.
After the imaging system has been properly aligned, the delivery shaft and the fin are withdrawn from the patient. Typically, the fin is first transitioned back to its compressed state, by retracting the fin into the outer shaft, by either advancing the outer shaft distally, and/or withdrawing the delivery shaft proximally.
A medical device, such as a stent (which, optionally, comprises a stent-graft), is introduced into vasculature of the subject, typically the one or more blood vessels from which the fin was withdrawn, or one or more other blood vessels in a vicinity of the one or more blood vessels from which the fin was withdrawn. The medical device is oriented using one or more images generated by the imaging system. Because the imaging system is properly aligned, as described above, the medical device can be properly aligned using images generated by the imaging system.
For some applications, the medical device, e.g., the stent, is rotationally oriented using the one or more images generated by the imaging system. For example, the stent may be shaped so as to define a lateral opening, and the lateral opening may be rotationally oriented using the imaging system, such as to face in a direction that is parallel to the image plane. If the imaging plane of the imaging system were not properly aligned as described above, the lateral opening would not be properly rotated to face the descending abdominal aorta, but instead would face another direction parallel to the misaligned imaging plane. Without the use of the alignment technique described herein, the imaging plane is sometimes misaligned with the plane indicative of the direction of blood flow by up to about 20 degrees, which results in the lateral opening being misaligned with the bifurcation with the descending abdominal aorta by up to about 20 degrees.
For some applications, the fin comprises a structural member and at least one substantially flow-resistant membrane member, which is securely mounted to at least a portion of the structural member. Typically, the fin is at least partially radiopaque, in order to facilitate radiographic imaging of the fin.
For some applications, the fin extends laterally from a portion of the delivery shaft, and a longitudinal axis of the portion coincides with the axis of rotation of the fin. For some applications, the fin is shaped so as to define one or more pivot joints, which rotatably couple the fin to the portion of the delivery shaft. Typically, the pivot joints are configured to facilitate at least 180 degrees of rotation of the fin around the delivery shaft, at least when the fin is in its expanded state. Typically, the pivot joints and the delivery shaft are configured to facilitate low-friction rotation of the fin around the delivery shaft, at least when the fin is in its expanded state.
For some applications, the fin has a substantially planar shape when in its expanded state. For example, the substantially planar shape may be a parallelogram, a rectangle, a square, a semicircle, a trapezoid, a shape defined by a curved segment having ends connected by a straight line, or a shape defined by an arc having ends connected by a straight line.
For some applications, the endovascular tool is used to treat an aneurysm, such as an aortic aneurism, or an aneurism of another blood vessel. For example, the aneurism may be of the sub-renal aorta.
There is therefore provided, in accordance with an application of the present invention, apparatus including an endovascular tool, which includes:
a longitudinal delivery shaft; and
a fin, which is coupled to the delivery shaft, and which is configured to assume (a) a compressed state for endoluminal delivery, and (b) an expanded state for endoluminal deployment, in which state the fin is configured to pivot around an axis of rotation.
Typically, the fin is configured such that, when the fin is placed in a blood flow path, at least a portion of the fin pivots in a direction that is indicative of a direction of blood flow in a vicinity of the fin.
For some applications, the fin is pivotable to rotate at least 180 degrees around the axis of rotation, at least when the fin is in its expanded state.
For some applications, the delivery shaft has a length of at least 10 cm.
For some applications, the fin, at least when in its expanded state, extends laterally from a portion of the delivery shaft, and a longitudinal axis of the portion coincides with the axis of rotation. For some applications, the longitudinal axis of the portion of the delivery shaft substantially lies within a plane generally defined by the fin when in its expanded state. For some applications, the fin includes a structural member and a substantially flow-resistant membrane member, which is securely mounted to at least a portion of the structural member, and the longitudinal axis of the portion of the delivery shaft substantially lies within a plane generally defined by the membrane member when the fin is in its expanded state.
For some applications, the fin is shaped so as to define one or more pivot joints, which rotatably couple the fin to the portion of the delivery shaft. For some applications, each of the one or more pivot joints is shaped so as to surround at least 210 degrees of the delivery shaft. For some applications, the pivot joints are configured to facilitate at least 180 degrees of rotation of the fin around the delivery shaft, at least when the fin is in its expanded state. For some applications, the pivot joints and the delivery shaft are configured to facilitate low-friction rotation of the fin around the delivery shaft, at least when the fin is in its expanded state. For some applications, the pivot joints and the delivery shaft are configured to provide a coefficient of static friction between the pivot joints and the delivery shaft of no more than 0.5. For some applications, the pivot joints and the delivery shaft are configured such that the pivot joints rotate with respect to the delivery shaft even when the fin is positioned in a blood flow of a healthy peripheral artery having a diameter of at least 3 mm in a subject having a systolic to diastolic blood pressure gradient of at least 30 mmHg. For some applications, at least one of the pivot joints (e.g., exactly one of the pivot joints, or two or more of the pivot joints) is axially fixed to the delivery shaft so as to prevent axial motion of the at least one of the pivot joints with respect to the delivery shaft.
For some applications, the fin includes a structural member and at least one substantially flow-resistant membrane member, which is securely mounted to at least a portion of the structural member, and the structural member is shaped so as to define the one or more pivot joints. For some applications, the fin includes a structural member and at least one substantially flow-resistant membrane member, which is securely mounted to at least a portion of the structural member, and the membrane member is shaped so as to define the one or more pivot joints.
For some applications, the portion of the delivery shaft has first and second ends from which respective first and second portions of the fin extend in a same radial direction from the longitudinal axis.
For some applications, the endovascular tool further includes a support structure, which is coupled to the delivery shaft, and the fin is coupled to the support structure, so as to be indirectly coupled to the delivery shaft.
For some applications, the endovascular tool includes exactly one fin.
For some applications, the fin is at least partially radiopaque. For some applications, the fin includes a structural member, and a plurality of radiopaque markers, which are fixed to the structural member, and which have a greater radiopacity per unit weight than that of the structural member.
For some applications, the fin includes a structural member and at least one substantially flow-resistant membrane member, which is securely mounted to at least a portion of the structural member. For some applications, the structural member includes a super-elastic material, such as a super-elastic metal alloy, e.g., Nitinol. For some applications, the flow-resistant membrane member includes an implantable-grade polymer, such as polytetrafluoroethylene (PTFE), e.g., expanded polytetrafluoroethylene (ePTFE). Alternatively, for some applications, the polymer includes a polyester. For some applications, the at least one membrane member has a surface area of between 9 and 50 mm2 when the fin is in its expanded state.
For some applications, a length of the delivery shaft is at least 10 times a greatest dimension of the fin measured in a direction parallel with the axis of rotation when the fin is in its expanded state.
For some applications, the fin has a substantially planar shape when in its expanded state. For example, the substantially planar shape may be selected from the group of shapes consisting of: a parallelogram, a rectangle, a square, a semicircle, a trapezoid, a shape defined by a curved segment having ends connected by a straight line, and a shape defined by an arc having ends connected by a straight line. For some applications, the fin has an airfoil shape when in its expanded state. For some applications, the fin is generally cylindrical when in its expanded state.
For some applications, the fin has a greatest length in a direction perpendicular to the axis of rotation, which greatest length is at least 200% greater when the fin is in its expanded state than when the fin is in its compressed state. For some applications, the fin has a greatest length in a direction perpendicular to the axis of rotation when the fin is in its expanded state, which greatest length is between 3 and 15 mm. For some applications, the fin has a greatest length in a direction perpendicular to the axis of rotation when the fin is in its compressed state, which greatest length is between 1.5 and 4 mm. For some applications, the fin is configured to assume the compressed state when constrained, and to assume the expanded state when relaxed. For some applications, an axial length of the fin along the axis of rotation is at least 50% greater when the fin is in its compressed state than when the fin is in its expanded state. For some applications, an axial length of the fin along the axis of rotation is between 6 and 20 mm when the fin is in its expanded state. For some applications, an axial length of the fin along the axis of rotation is between 10 and 40 mm when the fin is in its compressed state.
For any of the applications described above, the apparatus may further include a generally tubular outer shaft, in which the delivery shaft is at least partially positioned, and in which the fin is initially positioned in its compressed state at least partially alongside the delivery shaft. For some applications, the outer shaft, the delivery shaft, and the fin are configured such that longitudinal translation of the outer shaft with respect to the delivery shaft (a) in a first axial direction effects a transition of the fin from its compressed state to its expanded state, and (b) in a second axial direction opposite the first axial direction effects a transition of the fin from its expanded state to its compressed state. Alternatively, for some applications, the outer shaft, the delivery shaft, and the fin are configured such that rotation of the outer shaft with respect to the delivery shaft (a) in a first rotational direction effects a transition of the fin from its compressed state to its expanded state, and (b) in a second rotation direction opposite the first rotation direction effects a transition of the fin from its expanded state to its compressed state.
For any of the applications described above, the apparatus may further include an endovascular guidewire, and the delivery shaft is shaped so as to define a longitudinal bore therethrough, which is configured to allow deployment of the delivery shaft over the guidewire. There is further provided, in accordance with an application of the present invention, a method including:
providing an endovascular tool including a longitudinal delivery shaft and a fin coupled to the delivery shaft;
endoluminally introducing the endovascular tool into one or more blood vessels of a subject while the fin is in a compressed state; and
thereafter, transitioning the fin to an expanded state, in which state the fin is configured to pivot around an axis of rotation.
For some applications, the method further includes, after transitioning, generating a radiographic image of the fin using an imaging system. For some applications, the method further includes changing a spatial attitude of a component of the imaging system, responsively to the radiographic image, such that an image plane of the imaging system is generally parallel to a plane defined by the fin that is indicative of a direction of blood flow in a vicinity of the fin.
For some applications, the method further includes changing a spatial attitude of a component of the imaging system until an apparent shape of the fin, as shown in the radiographic image, no longer has a modified aspect ratio compared to its actual aspect ratio. For some applications, the method further includes,, after generating the image, assessing one or more apparent dimensions of the fin as shown in the image. For some applications, assessing includes assessing two or more apparent dimensions of the fin, and assessing at least one ratio between two of the two or more apparent dimensions. For some applications, the method further includes, after generating the image, assessing a reference dimension of a portion of the delivery shaft, and comparing the one or more apparent dimensions of the fin with the reference dimension. For some applications, assessing includes measuring the one or more apparent dimensions. For some applications, the method further includes, further including, after assessing, comparing the one or more apparent dimensions with one or more respective actual dimensions of the fin in its expanded state. For some applications, assessing includes assessing two or more apparent dimensions of the fin, and comparing includes comparing a ratio of two of the apparent dimensions with a ratio of two of the actual dimensions. For some applications, the method further includes changing a spatial attitude of a component of the imaging system responsively to the assessing. For some applications, changing includes changing the spatial attitude of the component such that an image plane of the imaging system is generally parallel to a plane defined by the fin that is indicative of a direction of blood flow in a vicinity of the fin. For some applications, assessing and changing the spatial attitude include repeatedly assessing and changing the spatial attitude until a desired relationship has been obtained between the apparent dimensions and the actual dimensions of the fin. For some applications, the imaging system is a fluoroscopy system, the component of the imaging system is a C-arm, and changing the spatial attitude includes changing the spatial attitude of the C-arm.
For some applications, the method further includes, after changing the spatial attitude:
withdrawing the endovascular tool;
introducing a medical device into vasculature of the subject; and
orienting the medical device using one or more images generated by the imaging system.
For some applications, orienting include rotationally orienting the medical device.
For some applications, the medical device is a stent, and introducing and orienting includes introducing and orienting the stent. For some applications, the stent is shaped so as to define a lateral opening, and orienting the stent includes orienting the lateral opening. For some applications, orienting the lateral opening includes orienting the lateral opening to face in a direction that is parallel to the image plane. For some applications, the stent includes two or more radiopaque features distributed around the lateral opening, and orienting the lateral opening includes orienting the lateral opening such that at least a portion of the radiopaque features are aligned with one another in the one or more images.
For some applications:
the delivery shaft is shaped so as to define a longitudinal bore therethrough, endoluminally introducing the endovascular tool includes endoluminally introducing a guidewire into the one or more blood vessels, and advancing the delivery shaft over the guidewire such that the guidewire passes through the bore,
withdrawing the endovascular tool includes leaving the guidewire in the one or more blood vessels, and
introducing the medical device includes introducing the medical device over the guidewire.
For some applications, endoluminally introducing includes positioning the fin in a vicinity of a bifurcation between at least two blood vessels. For some applications, endoluminally introducing includes positioning the delivery shaft in the one or more blood vessels such that the fin is aligned with the bifurcation. For some applications, positioning the delivery shaft includes positioning two portions of the delivery shaft in left and right common iliac arteries, respectively.
For some applications, the method further includes identifying that the patient suffers from an aneurysm, and endoluminally introducing includes endoluminally introducing the endovascular tool responsively to the identifying.
For some applications, transitioning includes transitioning the fin to its expanded state in which the fin extends laterally from a portion of the delivery shaft, and a longitudinal axis of the portion coincides with the axis of rotation. For some applications, providing the endovascular tool includes providing the endovascular tool in which the fin is shaped so as to define one or more pivot joints, which rotatably couple the fin to the portion of the delivery shaft.
For some applications, providing the endovascular tool includes providing the endovascular tool further including a support structure, which is coupled to the delivery shaft, and the fin is coupled to the support structure, so as to be indirectly coupled to the delivery shaft.
For some applications, providing the endovascular tool includes providing the endovascular tool including exactly one fin.
For some applications, providing the endovascular tool includes providing the endovascular tool in which the fin is at least partially radiopaque.
For some applications, providing the endovascular tool includes providing the endovascular tool in which the fin includes a structural member and at least one substantially flow-resistant membrane member, which is securely mounted to at least a portion of the structural member.
For some applications, transitioning includes transitioning the fin to its expanded in which state the fin has a substantially planar shape. For example, the substantially planar shape may be selected from the group of shapes consisting of: a parallelogram, a rectangle, a square, a semicircle, a trapezoid, a shape defined by a curved segment having ends connected by a straight line, and a shape defined by an arc having ends connected by a straight line.
For some applications, providing the endovascular tool includes providing the endovascular tool further including a generally tubular outer shaft, and endoluminally introducing includes endoluminally introducing the outer shaft in which the delivery shaft is at least partially positioned, and in which the fin is initially positioned in its compressed state at least partially alongside the delivery shaft. For some applications, transitioning the fin to its expanded state includes longitudinally translating the outer shaft with respect to the delivery shaft in a first axial direction, and further including subsequently longitudinally translating the outer shaft with respect to the delivery shaft in a second axial direction opposite the first axial direction to effect a transition of the fin from its expanded state to its compressed state. Alternatively, for some applications, transitioning the fin to its expanded state includes rotating the outer shaft with respect to the delivery shaft in a first axial direction, and further including subsequently rotating the outer shaft with respect to the delivery shaft in a second axial direction opposite the first axial direction to effect a transition of the fin from its expanded state to its compressed state. The present invention will be more fully understood from the following detailed description of embodiments thereof, taken together with the drawings, in which:
BRIEF DESCRIPTION OF THE DRAWINGS
Figs. 1A-C are schematic illustrations of an endovascular tool in compressed, partially-expanded, and expanded states, respectively, in accordance with an application of the present invention;
Figs. 2A-B are schematic illustrations of another configuration of the endovascular tool of Figs. 1 A-C in compressed and expanded states, respectively, in accordance with an application of the present invention;
Fig. 3 is a schematic illustration of yet another configuration of the endovascular tool of Figs. 1A-C in an expanded state, in accordance with an application of the present invention;
Fig. 4 is a schematic illustration of still another configuration of the endovascular tool of Figs. 1A-C in an expanded state, in accordance with an application of the present invention;
Fig. 5 is a schematic illustration of another configuration of the endovascular tool of Figs. 1A-C in an expanded state, in accordance with an application of the present invention;
Fig. 6 is a schematic illustration of yet another configuration of the endovascular tool of Figs. 1A-C in an expanded state, in accordance with an application of the present invention;
Fig. 7 is a schematic illustration of another configuration of the endovascular tool of Figs. 1A-C in an expanded state, in accordance with an application of the present invention;
Fig. 8 is a schematic illustration of yet another configuration of the endovascular tool of Figs. 1A-C in an expanded state, in accordance with an application of the present invention;
Figs. 9A-C are schematic illustrations of respective configurations of the endovascular tool of Figs. 1A-C in an expanded state, in accordance with respective applications of the present invention; and Figs. 10A-F are schematic illustrations of an exemplary transluminal procedure performed using the endovascular tool of Figs. 1A-C, in accordance with an application of the present invention.
DETAILED DESCRIPTION OF APPLICATIONS
Figs. 1A-C are schematic illustrations of an endovascular tool 10 in compressed, partially-expanded, and expanded states, respectively, in accordance with an application of the present invention. Endovascular tool 10 typically comprises a longitudinal delivery shaft 24 and a fin 20 coupled to the delivery shaft. The fin is configured to assume (a) a compressed state for endoluminal delivery (and, optionally, retrieval), as shown in Fig. 1A, and (b) an expanded state for endoluminal deployment, in which state the fin is configured to pivot around an axis of rotation 18, such as shown in Fig. 1C. Fin 20 typically assumes its compressed state when positioned a generally tubular outer shaft 22 at least partially alongside delivery shaft 24, initially before deployment of the fin, as described hereinbelow with reference to Fig. 10B, and, optionally, again subsequendy to performing a calibration procedure using tool 10. Fig. IB shows the fin in an intermediate, partially-expanded state, in which the fin is partially deployed from outer shaft 22. Typically, tool 10 comprises exactly one fin 20; alternatively, tool 10 comprises two or more fins (configuration not shown).
For some applications, fin 20 is relaxed in its expanded state. For some applications, the fin is configured to be self-expanding. For example, the fin may be heat- set to assume its expanded state. For some applications, fin 20 is configured to assume the compressed state when constrained (such as when within outer shaft 22), and to assume the expanded state when relaxed.
As described in more detail hereinbelow with reference to Figs. 10C-D, fin 20 is configured such that, when the fin is placed in a blood flow path, at least a portion of the fin pivots in a direction that is indicative of the direction of blood flow in a vicinity of the fin.
Typically, fin 20 is pivotable to rotate at least 180 degrees around axis of rotation 18, as schematically indicated by an arrow 26 in Fig. 1C, at least when the fin is in its expanded state.
For some applications, fin 20 comprises a structural member 32 and at least one substantially flow-resistant membrane member 34, which is securely mounted to at least a portion of the structural member, either directly or indirectly, such as by a plurality of coupling elements 36, e.g., sutures or threads. For some applications, structural member 32 comprises a super-elastic material, such as a super-elastic metal alloy, e.g., Nitinol. Membrane member 34 typically comprises a thin pliable sheet of material, which may, for example, comprise an implantable-grade polymer, such as polytetrafluoroethylene (PTFE), e.g., expanded polytetrafluoroethylene (ePTFE), a polyester, or a textile material (e.g., polyethylene terephthalate (PET)). For some applications, membrane member 34 has a surface area of at least 9 mm2, no more than 50 mm2, and/or between 9 and 50 mm2.
For some applications, as shown in Fig. 1A-C (and Figs. 2A-B, 3, 4, 5, 6, 8, 9A-C, and 10A-F, described hereinbelow), fin 20 extends laterally from a portion 28 of delivery shaft 24, and a longitudinal axis of portion 28 coincides with axis of rotation 18. For these applications, the longitudinal axis of portion 28 typically substantially lies within a plane 29 generally defined by fin 20 and/or membrane member 34 when the fin is in its expanded state, as shown in the side-view blow-up in Fig. 1C. Typically, portion 28 has first and second ends from which respective first and second portions of fin 20 extend in a same radial direction from longitudinal axis 18, for example, the direction indicated by a vector V in Fig. 1C. For other applications, such as described hereinbelow with reference to Fig. 7, axis of rotation 18 does not coincide with a longitudinal axis of delivery shaft 24.
For some applications, fin 20 (typically, structural member 32 and/or membrane member 34) is shaped so as to define one or more pivot joints 38, which rotatably couple the fin to portion 28 of delivery shaft 24. For example, the pivot joints may include exactly two pivot joints 38A and 38B, such as shown in Figs. 1A-C (and Figs. 3-6, described hereinbelow). Alternatively, exactly one pivot joint may be provided, such as shown in Fig. 8, or more than two pivot joints may be provided, such as shown in Figs. 2A-B, described hereinbelow. Typically, each of pivot joints 38 is shaped so as to surround at least 210 degrees of delivery shaft 24, such as at least 270 degrees, or 360 degrees (i.e., entirely surround the shaft), in order to be coupled to the delivery shaft. Typically, pivot joints 38 are configured to facilitate at least 180 degrees of rotation of the fin around the delivery shaft, as indicated by arrow 26 in Fig. 1C, at least when the fin is in its expanded state. Typically, pivot joints 38 and delivery shaft 24 are configured to facilitate low- friction rotation of fin 20 around the delivery shaft, at least when the fin is in its expanded state. For example, the pivot joints and the delivery shaft may be configured to provide a coefficient of static friction between the pivots and the delivery shaft of no more than 0.5, such as no more than 0.2. Alternatively or additionally, the pivot joints and the delivery shaft may be configured such that the pivot joints rotate with respect to the delivery shaft even when fin 20 is positioned in a blood flow of a healthy peripheral artery having a diameter of at least 3 mm in a subject having a systolic to diastolic blood pressure gradient of at least 30 mmHg.
For some applications, at least one (e.g., exactly one, or two or more) of pivot joints 38 is axially fixed to delivery shaft 24 so as to prevent axial motion of the at least one of the pivots with respect to the delivery shaft. Such fixation may aid in deployment of fin 20 from outer shaft 22, such as described hereinbelow with reference to Fig. IOC.
For some applications, fin 20 has a substantially planar shape when in its expanded state. For example, the substantially planar shape may be a parallelogram, a rectangle (such as shown in Figs. 2B, 3, and 4), a square, a semicircle, a trapezoid, a shape defined by a curved segment having ends connected by a straight line (such as shown Figs. 1C and 6), or a shape defined by an arc having ends connected by a straight line.
For other applications, fin 20 has an airfoil shape (e.g., a symmetrical airfoil) when in its expanded state (configuration not shown). For still other applications, fin 20 is generally cylindrical when in its expanded state, such as described hereinbelow with reference to Fig. 8.
For some applications, a length of delivery shaft 24 is at least 10 times, such as at least 20 times a greatest dimension Dl of fin 20 measured in a direction parallel with axis of rotation 18, when the fin is in its expanded state, as shown in Fig. 1C. For some applications, greatest dimension Dl is at least 3 mm, no more than 30 mm, and or between 3 and 30 mm. For some applications, a greatest dimension D2 of fin 20 measured in a direction parallel with axis of rotation 18, when the fin is in its compressed state, is at least 5 mm, no more than 50 mm, and/or between 5 and 50 mm, as shown in Fig. 1A. For some applications, delivery shaft 24 has a length of at least 10 cm, such as at least 50 cm.
For some applications, fin 20 has a greatest length LI in a direction perpendicular to axis of rotation 24 when the fin is in its expanded state, which greatest length is at least 3 mm, no more than 15 mm, and/or between 3 and 15 mm, as shown in Fig. 1C. For some applications, fin 20 has a greatest length L2 in a direction perpendicular to axis of rotation 24 when the fin is in its compressed state, which greatest length is at least 1.5 mm, no more than 4 mm, and/or between 1.5 and 4 mm, as shown in Fig. 1A. For some applications, greatest length LI (when the fin is in its expanded state) is at least 200% greater than greatest length L2 (when the fin is in its compressed state).
For some applications, an axial length L3 of fin 20 along axis of rotation 18 is at least 6 mm, no more than 20 mm, and/or between 6 and 20 mm when the fin is in its expanded state, as shown in Fig. 1C. (For some applications, greatest dimension Dl may be greater than axial length L3, when the greatest dimension does not coincide with axis of rotation 18.) For some applications, an axial length L4 of fin 20 along axis of rotation 18 is at least 10 mm, no more than 40 mm, and/or between 10 and 40 mm when the fin is in its compressed state, as shown in Fig. 1A. For some applications, axial length L4 (when the fin is in its compressed state) is at least 50% greater than axial length L3 (when the fin is in its expanded state).
For some applications, outer shaft 22, delivery shaft 24, and fin 20 are configured such that longitudinal translation of the outer shaft with respect to the delivery shaft (a) in a first axial direction (e.g., translation of the outer shaft to the left in Figs. 1A-C) effects a transition of the fin from its compressed state (such shown in Fig. 1A) to its expanded state (such as shown in Fig. 1C), and (b) in a second axial direction opposite the first axial direction effects a transition of the fin from its expanded state to its compressed state. In other words, the fin is configured to be capable of being compressed by the outer shaft when withdrawn into the outer shaft.
For some applications, outer shaft 22, delivery shaft 24, and fin 20 are configured such that rotation of the outer shaft with respect to the delivery shaft (a) in a first rotational direction effects a transition of the fin from its compressed state to its expanded state, and (b) in a second rotation direction opposite the first rotation direction effects a transition of the fin from its expanded state to its compressed state. For example, outer shaft 22 and delivery shaft 24 may be shaped so as to define a threading therebetween.
For some applications, an endovascular guidewire 30 is provided. Delivery shaft 24 is shaped so as to define a longitudinal bore therethrough, which is configured to allow deployment of the delivery shaft over the guidewire.
Reference is now made to Figs. 2A-B, which are schematic illustrations of another configuration of endo vascular tool 10 in compressed and expanded states, respectively, in accordance with an application of the present invention. Except as described below, this configuration of tool 10 is generally similar to the configuration described hereinabove with reference to Figs. 1A-C.
For some applications, as shown in Figs. 2A-B, fin 20 (typically, structural member 32 and/or membrane member 34) is shaped so as to define three pivot joints 38, which rotatably couple the fin to portion 28 of delivery shaft 24. First and second ones of these pivot joints (38A and 38B) extend to respective axial ends of portion 28 of dehvery shaft 24, and a third one of the pivot joints (38C) is positioned between first and second pivot joints 38A and 38B.
For some applications, as shown in Figs. 2A-B, structural member 32 is shaped so as to define all three pivot joints 38A, 38B, and 38C. Optionally, pivot joint 38C is not directly coupled to the remainder of structural member 32. Typically, membrane member 34 is coupled to the portion of structural member 32 that defines pivot joint 38C (such as by coupling elements 36), as well as to the portion of structural member 32 that defines pivot joints 38A and 38B.
Although fin 20 is shown in Fig. 2B as having the shape of a rectangle when in its expanded state, the fin may alternatively have another shapes, such as the shapes described hereinabove with reference to Figs. 1A-C, and or shown in any of the other figures.
One or more of the features of the configuration of fin 20 described with referenced to and/or shown in Figs. 2A-B may be implemented in combination with the features of fin 20 described with reference to and/or shown in Figs. 1A-C, 3, 4, 5, 6, 7, 8, and/or 9A-C.
Reference is now made to Fig. 3, which is a schematic illustration of yet another configuration of endo vascular tool 10 in an expanded state, in accordance with an application of the present invention. This configuration of tool 10 is generally similar to the configuration described hereinabove with reference to Figs. 2A-B, except that fin 20 comprises only first and second pivot joints 38A and 38B, and not third pivot joint 38C. One or more of the features of the configuration of fin 20 described with referenced to and or shown in Fig. 3 may be implemented in combination with the features of fin 20 described with reference to and/or shown in Figs. 1A-C, 2A-B, 4, 5, 6, 7, 8, and/or 9A-C.
Reference is now made to Fig. 4, which is a schematic illustration of still another configuration of endovascular tool 10 in an expanded state, in accordance with an application of the present invention. Except as described hereinbelow with reference to Figs. 1A-C and 2-7, this configuration of tool 10 is generally similar to the configuration described hereinabove with reference to Fig. 3.
One or more of the features of the configuration of fin 20 described with referenced to and/or shown in Fig. 4 may be implemented in combination with the features of fin 20 described with reference to and/or shown in Figs. 1A-C, 2A-B, 3, 5, 6, 7, 8, and/or 9A-C.
Reference is now made to Fig. 5, which is a schematic illustration of another configuration of endovascular tool 10 in an expanded state, in accordance with an application of the present invention. Except as described below, this configuration of tool 10 is generally similar to the configuration described hereinabove with reference to Fig. 4. In this configuration, structural member 32 is shaped so as to define one or more loops 42. These loops may serve to reduce kinking in at least one corner of the structural member, when the fin is folded into outer shaft 22.
One or more of the features of the configuration of fin 20 described with referenced to and/or shown in Fig. 5 may be implemented in combination with the features of fin 20 described with reference to and/or shown in Figs. 1A-C, 2A-B, 3, 4, 6, 7, 8, and/or 9A-C.
Reference is now made to Fig. 6, which is a schematic illustration of yet another configuration of endovascular tool 10 in an expanded state, in accordance with an application of the present invention. Except as described below, this configuration of tool 10 is generally similar to the configuration described hereinabove with reference to Figs. 1A-C. In this configuration pivot joints 38A and 38B come nearly in contact with each other along delivery shaft 24 when the fin is in its expanded state, such as within 2 mm of each other.
One or more of the features of the configuration of fin 20 described with referenced to and/or shown in Fig. 6 may be implemented in combination with the features of fin 20 described with reference to and/or shown in Figs. 1A-C, 2A-B, 3, 4, 5, 7, 8, and/or 9A-C.
Reference is now made to Fig. 7, which is a schematic illustration of another configuration of endo vascular tool 10 in an expanded state, in accordance with an application of the present invention. Except as described below, this configuration of tool 10 is generally similar to the configuration described hereinabove with reference to Figs. 1A-C.
In this configuration, endo vascular tool 10 further comprises a support structure 50, which is coupled to delivery shaft 24. For some applications, support structure 50 is rotationally fixed with respect to the delivery shaft and/or axially-fixed to the delivery shaft to prevent axial motion of the support structure with respect to the shaft. Alternatively, the support structure is only axially fixed to the shaft, only rotationally fixed to the shaft, or neither axially fixed nor rotationally fixed to the shaft. Fin 20 is coupled to support structure 50, so as to be indirectly coupled to delivery shaft 24. Fin 20 is configured to pivot around axis of rotation 18, which, in this configuration, does not coincide with the longitudinal axis of portion 28 of delivery shaft 24. For some applications, axis of rotation 18 coincides with an axis of a portion of support structure 50, such as shown in Fig. 7. For some applications, axis of rotation 18 is generally parallel with the longitudinal axis of portion 28 of delivery shaft 24, such as shown in Fig.
7. For other applications, the axis of rotation is not generally parallel with the longitudinal axis of portion 28 (configuration not shown).
One or more of the features of the configuration of fin 20 described with referenced to and/or shown in Fig. 7 may be implemented in combination with the features of fin 20 described with reference to and/or shown in Figs. 1A-C, 2A-B, 3, 4, 5,
8, and/or 9A-C.
Reference is again made to Figs. 1A-C and 2-7. For some applications, respective portions of structural member 32 that define pivot joints 38A and 38B have respective ends 44. For some applications, as shown in Figs. 1A-C, 2A-B, 3, 6, and 7, ends 44 face in axially-opposite directions along axis of rotation 18. For some of these applications, such as shown in Figs. 1A-C, 6, and 7, ends 44 face axially toward each other along axis of rotation 18, while for others of these applications, such as shown in Figs. 2A-B and 3, ends 44 face axially away from each other along axis of rotation 18 (this configuration may facilitate retraction of the fin into outer shaft 22). For other applications, such as shown in Figs. 4 and 5, ends 44 face in the same axial direction along axis of rotation 18.
Reference is now made to Fig. 8, which is a schematic illustration of yet another configuration of endo vascular tool 10 in an expanded state, in accordance with an application of the present invention. In this configuration, fin 20 is generally cylindrical when in its expanded state. For some applications, a central axis of the fin 20 is generally parallel to axis of rotation 18, as shown in Fig. 8, while for other applications, the central axis of the fin is generally perpendicular to the axis of rotation (configuration not shown).
Reference is made to Figs. 9A-C, which are schematic illustrations of respective configurations of endo vascular tool 10 in an expanded state, in accordance with respective applications of the present invention. Typically, fin 20 is at least partially radiopaque, in order to facilitate radiographic imaging of the fin, such as described hereinbelow with reference to Fig. 10D. For some applications, fin 20 comprises a plurality of radiopaque markers 40, which are fixed to structural member 40, and have a greater radiopacity per unit weight than that of the structural member. For some applications, at least some of radiopaque markers 40 comprise small circular or semispherical elements, such as shown in Fig. 9A. Alternatively or additionally, at least some of radiopaque markers 40 comprise short tube segment, as shown in Figs. 9B and 9C, which are wrapped around respective portions of structural member 32. Alternatively or additionally, some or all of radiopaque markers 40 are fixed to membrane member 34 (configuration not shown). Although Figs. 9A-C illustrate radiopaque markers 40 applied to the configuration of fin 20 described hereinabove with reference to Figs. 1A-C, the radiopaque markers may be similarly applied to the other configurations of fin 20 described herein, such as with reference to Figs. 2A-B, 3, 4, 5, 6, 7, and/or 8.
Reference is now made to Figs. 10A-F, which are schematic illustrations of an exemplary transluminal procedure performed using endo vascular tool 10, in accordance with an application of the present invention. Although this procedure is illustrated using the configuration of tool 10 described hereinabove with reference to Figs. 1A-C, the procedure may also be used to deploy the other configurations of tool 10 described herein, mutatis mutandis.
As shown in Fig. 10A, the exemplary procedures begins by endoluminally introducing guidewire 30 into one or more blood vessels of a subject. For example, fin 20 may be positioned in a vicinity of a bifurcation between at least two blood vessels, optionally aligned with the bifurcation, as shown in Fig. 10A. By way of example, in Fig. 10A the guidewire is shown introduced into left and right common iliac arteries 100A and 100B.
As shown in Fig. 10B, endovascular tool 10 is endoluminally introduced into the one or more blood vessels while fin 20 is in its compressed state. Typically, in order to endoluminally introduce the tool, delivery shaft 24 is passed over guidewire 30 such that the guidewire passes through a bore defined by the delivery shaft, and outer shaft 22 is also passed over the guidewire. Fin 20 is initially positioned in its compressed state within outer shaft 22, typically near a distal end of the outer shaft. Although delivery shaft 24 is shown by way of illustration in Fig. 10B as extending slightly distally out of the distal end of outer shaft 22, delivery shaft 24 does not necessarily extend out of outer shaft 22 at this stage of deployment.
Delivery shaft 24 and outer shaft 22 are longitudinally translated with respect to each other, thereby delivering fin 20 from the outer shaft, and transitioning fin 20 to its expanded state, as shown in Fig. IOC. For some applications, as shown, this relative longitudinal translation is effected by holding delivery shaft 24 in place as outer shaft 22 is withdrawn proximally. Alternatively, this relative longitudinal translation is effected by holding outer shaft 22 in place as delivery shaft 24 is advanced distally (technique not shown). As mentioned above with reference to Figs. 1A-C, for some applications, at least one (e.g., exactly one, or two or more) of pivot joints 38 is axially fixed to delivery shaft 24 so as to prevent axial motion of the at least one of the pivots with respect to the delivery shaft. Such fixation may aid in deployment of the fin from outer shaft 22, by preventing fin 20 from moving with respect to outer shaft 22 as the delivery shaft and outer shaft are longitudinally translated with respect to each other.
In its expanded state, the fin is configured to pivot around the axis of rotation, as described hereinabove with reference to Figs. 1A-C. When the fin is thus placed in a blood flow path (in this exemplary case, blood flow downstream from a descending abdominal aorta 102 into iliac arteries 100A and 100B), at least a portion of the fin pivots in a direction that is indicative of the direction of blood flow in the vicinity of the fin, as indicated by a vector V in Fig. IOC, perhaps best seen in Section A--A thereof. Tool 10 is positioned such that axis of rotation 18 (and, in the illustrated configuration, portion 28 of delivery shaft 24) is generally perpendicular to the direction of blood flow, in the vicinity of the axis of rotation.
As shown in Fig. 10D, a radiographic image (such as a fluoroscopy image) of fin 20 is generated using an imaging system 120 (such as a fluoroscopy imaging system). The image is used to align an image plane of imaging system 120 generally parallel to a plane 122 defined by the fin that is indicative of the direction of blood flow in the vicinity of the fin. Plane 122 is defined by (a) axis of rotation 18 (and, in the illustrated configuration, portion 28 of delivery shaft 24), and (b) vector V oriented in the direction that fin 20 extends from axis of rotation 18. (An "image plane," as used herein, including in the claims, is a plane that is perpendicular to the optical axis at any axial image point of the imaging system.)
In order to align the image plane of imaging system 120, a spatial attitude (i.e., an orientation or angular position) of a component of the imaging system (such as a C-arm 124) is changed (sometimes repeatedly), responsively to the radiographic image, until the image plane is generally parallel to plane 122.
For some applications, in order to align the image plane, after generating the image, one or more apparent dimensions of fin 20 as shown in the image are assessed, and the spatial attitude of the component of the imaging system is changed responsively to the assessing. In general, fin 20 (optionally, as represented by radiopaque markers 40) will appear distorted in the image to the extent that the image plane is not parallel with plane 122. The spatial attitude of the component of the imaging system is adjusted until fin 20 no longer appears distorted, indicating that the image plane and plane 122 are parallel. In other words, the spatial attitude of the component of the imaging system is adjusted until an apparent shape of the fin (either of the entire fin, or of a portion thereof, such as one or more radiographic markers thereof), as shown in the radiographic image, is no longer distorted compared to an actual shape of the fin, i.e., no longer has a modified aspect ratio compared to its actual aspect ratio. Typically, the assessing and changing of the spatial attitude are repeated until a desired relationship has been obtained between the apparent dimensions and the actual dimensions of the fin.
For example, two or more apparent dimensions of the fin may be assessed, and at least one ratio between two of the two or more apparent dimensions may be assessed. Alternatively or additionally, a reference dimension of a portion of the delivery shaft may be assessed, and the one or more apparent dimensions of the fin are compared with the reference dimension. In either case, the dimensions of the fin may include one or more of the following: one or more distances between respective sets of two features of the fin (e.g., radiopaque markers 40), a greatest width of the fin in a direction parallel with axis of rotation 24, and/or a greatest length of the fin in a direction perpendicular to axis of rotation 24.
For some applications, assessing comprises measuring the one or more apparent dimensions. For some applications, the one or more apparent dimensions are compared with one or more respective actual dimensions of the fin in its expanded state. For some applications, two or more apparent dimensions of the fin are assessed, and a ratio of two of the apparent dimensions are compared with a ratio of two of the actual dimensions.
After the imaging system has been properly aligned, delivery shaft 24 and fin 20 are withdrawn from the patient. Typically, fin 20 is first retracted into outer shaft 22, by either advancing outer shaft 22 distally, or withdrawing delivery shaft 24 proximally, until the fin reassumes its contracted state.
As shown in Fig. 10E, a medical device, such as a stent 106 (which, optionally, comprises a stent-graft), is introduced into vasculature of the subject, typically the one or more blood vessels from which the fin was withdrawn, or one or more other blood vessels in a vicinity of the one or more blood vessels from which the fin was withdrawn. The medical device is oriented using one or more images generated by the imaging system. Because the imaging system is properly aligned, as described above, the medical device can be properly aligned, for example, specifically in the rotational dimension, using images generated by the imaging system.
For some applications, the medical device, e.g., stent 106, is rotationally oriented using the one or more images generated by the imaging system. For example, the stent may be shaped so as to define a lateral opening 123, and the lateral opening may be rotationally oriented using the imaging system, such as to face in a direction that is parallel to the image plane. In the exemplary deployment procedure illustrated in Figs. 10A-F, lateral opening 123 is oriented to face the opening between descending abdominal aorta 102 and left and right common iliac arteries 100A and 100B. If the imaging plane of imaging system 120 were not properly aligned as described above, the lateral opening would not be properly rotated to face the descending abdominal aorta, but instead would face another direction parallel to the misaligned imaging plane.
For some applications, stent 106 includes two or more radiopaque features 124 distributed around lateral opening 123. For some applications, lateral opening 123 is oriented such that at least a portion of radiopaque features 124 are aligned with one another in the one or more images. For example, as shown in Fig. 10E, stent 106 may be properly rotationally aligned when radiopaque feature 124A appears to coincide with radiopaque feature 124B in the two-dimensional radiographic image (because radiopaque feature 124A is directly above radiopaque feature 124B when viewed in the properly- aligned image plane), and radiopaque feature 124D appears to coincide with radiopaque feature 124C.
For some applications, the medical device, e.g., stent 106, is delivered in a radially-compressed state within a delivery shaft 130, as shown in Fig. 10E. The medical device is typically aligned while still compressed in the delivery shaft, which is generally readily rotated in the vasculature. Optionally, when delivery shaft 24 and fin 20 are withdrawn, as described above, guidewire 30 is left in the one or more blood vessels, and the medical device is introduced over the guidewire.
As shown in Fig. 10F, once properly aligned, the medical device, e.g., stent 106, is delivered from the delivery shaft, and transitions to a radially-expanded state. If necessary for precise alignment, the medical device typically can be further slightly rotated even after expansion thereof. For some applications, stent 106 may be configured using techniques described in US Patent Application Publication 2010/0063575, which is incorporated herein by reference, such as regarding stent graft component 60 thereof. For some applications, the techniques described herein are used for rotationally aligning stent graft component 60 of the '575 publication, optionally in combination with other apparatus and or methods described in the '575 publication. For some applications, additional stents (e.g., stent-grafts) are deployed in combination with stent 106, either before or after deploying stent 106, such as using techniques described in one or more of the patent applications incorporated hereinbelow by reference.
For some applications of the present invention, a kit is provided that comprises endovascular tool 10 and at least one medical device, such as a stent (e.g., a stent-graft). For some applications, the kit further comprises delivery shaft 130 and/or guidewire 30. For some applications, endo vascular tool 10 is used to treat an aneurysm 104, such as an aortic aneurism, or an aneurism of another blood vessel. For example, the aneurism may be of the sub-renal aorta, as shown in Figs. 10A-F. For some applications, a method is provided that comprises identifying that a patient suffers from an aneurysm, such as an aortic aneurism (e.g., a sub-renal aortic aneurism), and, responsively to the identifying, endoluminally introducing endovascular tool 10 responsively to the identifying, and, optionally, a medical device, such as a stent, e.g., a stent-graft. Techniques for identifying that a patient suffers from an aneurism are well known, and thus not described herein.
Although endovascular tool 10 has sometimes been described hereinabove as being deployed in the common iliac arteries in a vicinity of a bifurcation with the descending abdominal aorta, the endovascular tool may, for some applications, also be deployed in other body lumens, such as at other branching body lumens. For example, the tool may be deployed in the aortic arch in a vicinity of one of the branches of the aortic arch, and also when placing a fenestrated stent between the common carotid artery and either the internal or external carotid artery, and an additional stent between the fenestration of the aforementioned stent and the other carotid artery.
The scope of the present invention includes embodiments described in the following applications, which are assigned to the assignee of the present application and are incorporated herein by reference. In an embodiment, techniques and apparatus described in one or more of the following applications are combined with techniques and apparatus described herein:
• PCT Application PCT/IL2008/000287, filed March 5, 2008, which
published as PCT Publication WO 2008/107885 to Shalev et al., and US Application 12/529,936 in the national stage thereof, which published as US Patent Application Publication 2010/0063575
• US Application 12/529,936, which published as US Patent Application
Publication 2010/0063575 to Shalev et al.
• US Provisional Application 60/892,885, filed March 5, 2007
• US Provisional Application 60/991 ,726, filed December 2, 2007
· US Provisional Application 61/219,758, filed June 23, 2009
• US Provisional Application 61/221,074, filed June 28, 2009 PCT Application PCT TO2010/052861, filed June 23, 2010
PCT Application PCT IL2010/000564, filed July 14, 2010
PCT Application PCT/IL2010/000917, filed November 4, 2010
PCT Application PCT/IL2010/000999, filed November 30, 2010, entitled, "Multi-component stent-graft system for implantation in a blood vessel with multiple branches"
PCT Application PCT/IL2010/001018, filed December 2, 2010, entitled, "Endovascular fenestrated stent-grafting"
PCT Application PCT/TL2010/001037, filed December 8, 2010, entitled, "Endovascular stent-graft system with fenestrated and crossing stent- grafts"
It will be appreciated by persons skilled in the art that the present invention is not limited to what has been particularly shown and described hereinabove. Rather, the scope of the present invention includes both combinations and subcombinations of the various features described hereinabove, as well as variations and modifications thereof that are not in the prior art, which would occur to persons skilled in the art upon reading the foregoing description.

Claims

1. Apparatus comprising an endovascular tool, which comprises:
a longitudinal delivery shaft; and
a fin, which is coupled to the delivery shaft, and which is configured to assume (a) a compressed state for endoluminal delivery, and (b) an expanded state for endoluminal deployment, in which state the fin is configured to pivot around an axis of rotation.
2. The apparatus according to claim 1, wherein the fin is configured such that, when the fin is placed in a blood flow path, at least a portion of the fin pivots in a direction that is indicative of a direction of blood flow in a vicinity of the fin.
3. The apparatus according to claim 1, wherein the fin is pivotable to rotate at least 180 degrees around the axis of rotation, at least when the fin is in its expanded state.
4. The apparatus according to claim 1, wherein the delivery shaft has a length of at least 10 cm.
5. The apparatus according to claim 1, wherein the fin, at least when in its expanded state, extends laterally from a portion of the delivery shaft, and wherein a longitudinal axis of the portion coincides with the axis of rotation.
6. The apparatus according to claim 5, wherein the longitudinal axis of the portion of the delivery shaft substantially lies within a plane generally defined by the fin when in its expanded state.
7. The apparatus according to claim 5, wherein the fin comprises a structural member and a substantially flow-resistant membrane member, which is securely mounted to at least a portion of the structural member, and wherein the longitudinal axis of the portion of the delivery shaft substantially lies within a plane generally defined by the membrane member when the fin is in its expanded state.
8. The apparatus according to claim 5, wherein the fin is shaped so as to define one or more pivot joints, which rotatably couple the fin to the portion of the delivery shaft.
9. The apparatus according to claim 8, wherein each of the one or more pivot joints is shaped so as to surround at least 210 degrees of the delivery shaft.
10. The apparatus according to claim 8, wherein the pivot joints are configured to facilitate at least 180 degrees of rotation of the fin around the delivery shaft, at least when the fin is in its expanded state.
11. The apparatus according to claim 8, wherein the pivot joints and the delivery shaft are configured to facilitate low-friction rotation of the fin around the delivery shaft, at least when the fin is in its expanded state.
12. The apparatus according to claim 8, wherein the pivot joints and the delivery shaft are configured to provide a coefficient of static friction between the pivot joints and the delivery shaft of no more than 0.5.
13. The apparatus according to claim 8, wherein the pivot joints and the delivery shaft are configured such that the pivot joints rotate with respect to the delivery shaft even when the fin is positioned in a blood flow of a healthy peripheral artery having a diameter of at least 3 mm in a subject having a systolic to diastolic blood pressure gradient of at least 30 mmHg.
14. The apparatus according to claim 8, wherein at least one of the pivot joints is axially fixed to the delivery shaft so as to prevent axial motion of the at least one of the pivot joints with respect to the delivery shaft.
15. The apparatus according to claim 14, wherein exactly one of the pivot joints is axially fixed to the delivery shaft.
16. The apparatus according to claim 14, wherein two or more of the pivot joints are axially fixed to the delivery shaft.
17. The apparatus according to claim 8, wherein the fin comprises a structural member and at least one substantially flow-resistant membrane member, which is securely mounted to at least a portion of the structural member, and wherein the structural member is shaped so as to define the one or more pivot joints.
18. The apparatus according to claim 8, wherein the fin comprises a structural member and at least one substantially flow-resistant membrane member, which is securely mounted to at least a portion of the structural member, and wherein the membrane member is shaped so as to define the one or more pivot joints.
19. The apparatus according to claim 5, wherein the portion of the delivery shaft has first and second ends from which respective first and second portions of the fin extend in a same radial direction from the longitudinal axis.
20. The apparatus according to claim 1, wherein the endo vascular tool further comprises a support structure, which is coupled to the delivery shaft, and wherein the fin is coupled to the support structure, so as to be indirectly coupled to the delivery shaft.
21. The apparatus according to claim 1, wherein the endo vascular tool comprises exactly one fin.
22. The apparatus according to claim 1, wherein the fin is at least partially radiopaque.
23. The apparatus according to claim 22, wherein the fin comprises:
a structural member; and
a plurality of radiopaque markers, which are fixed to the structural member, and which have a greater radiopacity per unit weight than that of the structural member.
24. The apparatus according to claim 1, wherein the fin comprises a structural member and at least one substantially flow-resistant membrane member, which is securely mounted to at least a portion of the structural member.
25. The apparatus according to claim 24, wherein the structural member comprises a super-elastic material.
26. The apparatus according to claim 25, wherein the super-elastic material comprises a super-elastic metal alloy.
27. The apparatus according to claim 26, wherein the super-elastic metal alloy comprises Nitinol.
28. The apparatus according to claim 24, wherein the flow-resistant membrane member comprises an implantable-grade polymer.
29. The apparatus according to claim 28, wherein the polymer comprises polytetrafluoroethylene (PTFE).
30. The apparatus according to claim 29, wherein the PTFE comprises expanded polytetrafluoroethylene (ePTFE).
31. The apparatus according to claim 28, wherein the polymer comprises a polyester.
32. The apparatus according to claim 24, wherein the at least one membrane member has a surface area of between 9 and 50 mm2 when the fin is in its expanded state.
33. The apparatus according to claim 1, wherein a length of the delivery shaft is at least 10 times a greatest dimension of the fin measured in a direction parallel with the axis of rotation when the fin is in its expanded state.
34. The apparatus according to claim 1, wherein the fin has a substantially planar shape when in its expanded state.
35. The apparatus according to claim 34, wherein the substantially planar shape is selected from the group of shapes consisting of: a parallelogram, a rectangle, a square, a semicircle, a trapezoid, a shape defined by a curved segment having ends connected by a straight line, and a shape defined by an arc having ends connected by a straight line.
36. The apparatus according to claim 1, wherein the fin has an airfoil shape when in its expanded state.
37. The apparatus according to claim 1, wherein the fin is generally cylindrical when in its expanded state.
38. The apparatus according to claim 1, wherein the fin has a greatest length in a direction perpendicular to the axis of rotation, which greatest length is at least 200% greater when the fin is in its expanded state than when the fin is in its compressed state.
39. The apparatus according to claim 1, wherein the fin has a greatest length in a direction perpendicular to the axis of rotation when the fin is in its expanded state, which greatest length is between 3 and 15 mm.
40. The apparatus according to claim 1, wherein the fin has a greatest length in a direction perpendicular to the axis of rotation when the fin is in its compressed state, which greatest length is between 1.5 and 4 mm.
41. The apparatus according to claim 1, wherein the fin is configured to assume the compressed state when constrained, and to assume the expanded state when relaxed.
42. The apparatus according to claim 1, wherein an axial length of the fin along the axis of rotation is at least 50% greater when the fin is in its compressed state than when the fin is in its expanded state.
43. The apparatus according to claim 1, wherein an axial length of the fin along the axis of rotation is between 6 and 20 mm when the fin is in its expanded state.
44. The apparatus according to claim 1, wherein an axial length of the fin along the axis of rotation is between 10 and 40 mm when the fin is in its compressed state.
45. The apparatus according to any one of claims 1-44, further comprising a generally tubular outer shaft, in which the delivery shaft is at least partially positioned, and in which the fin is initially positioned in its compressed state at least partially alongside the delivery shaft.
46. The apparatus according to claim 45, wherein the outer shaft, the delivery shaft, and the fin are configured such that longitudinal translation of the outer shaft with respect to the delivery shaft (a) in a first axial direction effects a transition of the fin from its compressed state to its expanded state, and (b) in a second axial direction opposite the first axial direction effects a transition of the fin from its expanded state to its compressed state.
47. The apparatus according to claim 45, wherein the outer shaft, the delivery shaft, and the fin are configured such that rotation of the outer shaft with respect to the delivery shaft (a) in a first rotational direction effects a transition of the fin from its compressed state to its expanded state, and (b) in a second rotation direction opposite the first rotation direction effects a transition of the fin from its expanded state to its compressed state.
48. The apparatus according to any one of claims 1-44, further comprising an endovascular guidewire, wherein the delivery shaft is shaped so as to define a longitudinal bore therethrough, which is configured to allow deployment of the delivery shaft over the guidewire.
49. A method comprising:
providing an endovascular tool including a longitudinal delivery shaft and a fin coupled to the delivery shaft;
endoluminally introducing the endovascular tool into one or more blood vessels of a subject while the fin is in a compressed state; and
thereafter, transitioning the fin to an expanded state, in which state the fin is configured to pivot around an axis of rotation.
50. The method according to claim 49, further comprising, after transitioning, generating a radiographic image of the fin using an imaging system.
51. The method according to claim 50, further comprising changing a spatial attitude of a component of the imaging system, responsively to the radiographic image, such that an image plane of the imaging system is generally parallel to a plane defined by the fin that is indicative of a direction of blood flow in a vicinity of the fin.
52. The method according to claim 50, further comprising changing a spatial attitude of a component of the imaging system until an apparent shape of the fin, as shown in the radiographic image, no longer has a modified aspect ratio compared to its actual aspect ratio.
53. The method according to claim 50, further comprising, after generating the image, assessing one or more apparent dimensions of the fin as shown in the image.
54. The method according to claim 53, wherein assessing comprises assessing two or more apparent dimensions of the fin, and assessing at least one ratio between two of the two or more apparent dimensions.
55. The method according to claim 53, further comprising, after generating the image, assessing a reference dimension of a portion of the delivery shaft, and comparing the one or more apparent dimensions of the fin with the reference dimension.
56. The method according to claim 53, wherein assessing comprises measuring the one or more apparent dimensions.
57. The method according to claim 53, further comprising, after assessing, comparing the one or more apparent dimensions with one or more respective actual dimensions of the fin in its expanded state.
58. The method according to claim 57, wherein assessing comprises assessing two or more apparent dimensions of the fin, and wherein comparing comprises comparing a ratio of two of the apparent dimensions with a ratio of two of the actual dimensions.
59. The method according to claim 53, further comprising changing a spatial attitude of a component of the imaging system responsively to the assessing.
60. The method according to claim 59, wherein changing comprises changing the spatial attitude of the component such that an image plane of the imaging system is generally parallel to a plane defined by the fin that is indicative of a direction of blood flow in a vicinity of the fin.
61. The method according to claim 59, wherein assessing and changing the spatial attitude comprise repeatedly assessing and changing the spatial attitude until a desired relationship has been obtained between the apparent dimensions and the actual dimensions of the fin.
62. The method according to claim 59, wherein the imaging system is a fluoroscopy system, wherein the component of the imaging system is a C-arm, and wherein changing the spatial attitude comprises changing the spatial attitude of the C-arm.
63. The method according to any one of claims 51, 52, and 59, further comprising, after changing the spatial attitude:
withdrawing the endovascular tool;
introducing a medical device into vasculature of the subject; and
orienting the medical device using one or more images generated by the imaging system.
64. The method according to claim 63, wherein orienting comprise rotationally orienting the medical device.
65. The method according to claim 63, wherein the medical device is a stent, and wherein introducing and orienting comprises introducing and orienting the stent.
66. The method according to claim 65, wherein the stent is shaped so as to define a lateral opening, and wherein orienting the stent comprises orienting the lateral opening.
67. The method according to claim 66, wherein orienting the lateral opening comprises orienting the lateral opening to face in a direction that is parallel to the image plane.
68. The method according to claim 67, wherein the stent includes two or more radiopaque features distributed around the lateral opening, and wherein orienting the lateral opening comprises orienting the lateral opening such that at least a portion of the radiopaque features are aligned with one another in the one or more images.
69. The method according to claim 63,
wherein the delivery shaft is shaped so as to define a longitudinal bore therethrough,
wherein endoluminally introducing the endovascular tool comprises endoluminally introducing a guidewire into the one or more blood vessels, and advancing the delivery shaft over the guidewire such that the guidewire passes through the bore, wherein withdrawing the endovascular tool comprises leaving the guidewire in the one or more blood vessels, and wherein introducing the medical device comprises introducing the medical device over the guidewire.
70. The method according to claim 49, wherein endoluminally introducing comprises positioning the fin in a vicinity of a bifurcation between at least two blood vessels.
71. The method according to claim 70, wherein endoluminally introducing comprises positioning the delivery shaft in the one or more blood vessels such that the fin is aligned with the bifurcation.
72. The method according to claim 71, wherein positioning the delivery shaft comprises positioning two portions of the delivery shaft in left and right common iliac arteries, respectively.
73. The method according to claim 49, further comprising identifying that the patient suffers from an aneurysm, and endoluminally introducing comprises endoluminally introducing the endovascular tool responsively to the identifying.
74. The method according to claim 49, wherein transitioning comprises transitioning the fin to its expanded state in which the fin extends laterally from a portion of the delivery shaft, and a longitudinal axis of the portion coincides with the axis of rotation.
75. The method according to claim 74, wherein providing the endovascular tool comprises providing the endovascular tool in which the fin is shaped so as to define one or more pivot joints, which rotatably couple the fin to the portion of the delivery shaft.
76. The method according to claim 49, wherein providing the endovascular tool comprises providing the endovascular tool further including a support structure, which is coupled to the delivery shaft, and wherein the fin is coupled to the support structure, so as to be indirectly coupled to the delivery shaft.
77. The method according to claim 49, wherein providing the endovascular tool comprises providing the endovascular tool including exactly one fin.
78. The method according to claim 49, wherein providing the endovascular tool comprises providing the endovascular tool in which the fin is at least partially radiopaque.
79. The method according to claim 49, wherein providing the endovascular tool comprises providing the endovascular tool in which the fin includes a structural member and at least one substantially flow-resistant membrane member, which is securely mounted to at least a portion of the structural member.
80. The method according to claim 49, wherein transitioning comprises transitioning the fin to its expanded in which state the fin has a substantially planar shape.
81. The method according to claim 80, wherein the substantially planar shape is selected from the group of shapes consisting of: a parallelogram, a rectangle, a square, a semicircle, a trapezoid, a shape defined by a curved segment having ends connected by a straight line, and a shape defined by an arc having ends connected by a straight line.
82. The method according to claim 49, wherein providing the endovascular tool comprises providing the endovascular tool further including a generally tubular outer shaft, and wherein endoluminally introducing comprises endoluminally introducing the outer shaft in which the delivery shaft is at least partially positioned, and in which the fin is initially positioned in its compressed state at least partially alongside the delivery shaft.
83. The method according to claim 82, wherein transitioning the fin to its expanded state comprises longitudinally translating the outer shaft with respect to the delivery shaft in a first axial direction, and further comprising subsequently longitudinally translating the outer shaft with respect to the delivery shaft in a second axial direction opposite the first axial direction to effect a transition of the fin from its expanded state to its compressed state.
84. The method according to claim 82, wherein transitioning the fin to its expanded state comprises rotating the outer shaft with respect to the delivery shaft in a first axial direction, and further comprising subsequently rotating the outer shaft with respect to the delivery shaft in a second axial direction opposite the first axial direction to effect a transition of the fin from its expanded state to its compressed state.
PCT/IL2010/001087 2009-12-31 2010-12-27 Endovascular flow direction indicator WO2011080738A1 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
US13/519,971 US8956397B2 (en) 2009-12-31 2010-12-27 Endovascular flow direction indicator
CA2785953A CA2785953C (en) 2009-12-31 2010-12-27 Endovascular flow direction indicator
EP10840702.4A EP2519166A4 (en) 2009-12-31 2010-12-27 Endovascular flow direction indicator

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US29142709P 2009-12-31 2009-12-31
US61/291,427 2009-12-31

Publications (1)

Publication Number Publication Date
WO2011080738A1 true WO2011080738A1 (en) 2011-07-07

Family

ID=44226220

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IL2010/001087 WO2011080738A1 (en) 2009-12-31 2010-12-27 Endovascular flow direction indicator

Country Status (4)

Country Link
US (1) US8956397B2 (en)
EP (1) EP2519166A4 (en)
CA (1) CA2785953C (en)
WO (1) WO2011080738A1 (en)

Cited By (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8317856B2 (en) 2007-03-05 2012-11-27 Endospan Ltd. Multi-component expandable supportive bifurcated endoluminal grafts and methods for using same
US8486131B2 (en) 2007-12-15 2013-07-16 Endospan Ltd. Extra-vascular wrapping for treating aneurysmatic aorta in conjunction with endovascular stent-graft and methods thereof
US8574287B2 (en) 2011-06-14 2013-11-05 Endospan Ltd. Stents incorporating a plurality of strain-distribution locations
WO2014020609A1 (en) 2012-08-01 2014-02-06 Endospan Ltd. Stent-grafts configured for post-implantation expansion
US8870938B2 (en) 2009-06-23 2014-10-28 Endospan Ltd. Vascular prostheses for treating aneurysms
US8945203B2 (en) 2009-11-30 2015-02-03 Endospan Ltd. Multi-component stent-graft system for implantation in a blood vessel with multiple branches
US8951298B2 (en) 2011-06-21 2015-02-10 Endospan Ltd. Endovascular system with circumferentially-overlapping stent-grafts
US8956397B2 (en) 2009-12-31 2015-02-17 Endospan Ltd. Endovascular flow direction indicator
US8979892B2 (en) 2009-07-09 2015-03-17 Endospan Ltd. Apparatus for closure of a lumen and methods of using the same
US9101457B2 (en) 2009-12-08 2015-08-11 Endospan Ltd. Endovascular stent-graft system with fenestrated and crossing stent-grafts
US9254209B2 (en) 2011-07-07 2016-02-09 Endospan Ltd. Stent fixation with reduced plastic deformation
US9427339B2 (en) 2011-10-30 2016-08-30 Endospan Ltd. Triple-collar stent-graft
US9468517B2 (en) 2010-02-08 2016-10-18 Endospan Ltd. Thermal energy application for prevention and management of endoleaks in stent-grafts
US9486341B2 (en) 2011-03-02 2016-11-08 Endospan Ltd. Reduced-strain extra-vascular ring for treating aortic aneurysm
US9526638B2 (en) 2011-02-03 2016-12-27 Endospan Ltd. Implantable medical devices constructed of shape memory material
US9597204B2 (en) 2011-12-04 2017-03-21 Endospan Ltd. Branched stent-graft system
US9668892B2 (en) 2013-03-11 2017-06-06 Endospan Ltd. Multi-component stent-graft system for aortic dissections
US9770350B2 (en) 2012-05-15 2017-09-26 Endospan Ltd. Stent-graft with fixation elements that are radially confined for delivery
US9839510B2 (en) 2011-08-28 2017-12-12 Endospan Ltd. Stent-grafts with post-deployment variable radial displacement
US9855046B2 (en) 2011-02-17 2018-01-02 Endospan Ltd. Vascular bands and delivery systems therefor
US9993360B2 (en) 2013-01-08 2018-06-12 Endospan Ltd. Minimization of stent-graft migration during implantation
US10485684B2 (en) 2014-12-18 2019-11-26 Endospan Ltd. Endovascular stent-graft with fatigue-resistant lateral tube
US10603197B2 (en) 2013-11-19 2020-03-31 Endospan Ltd. Stent system with radial-expansion locking

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20150144568A (en) * 2014-06-17 2015-12-28 (주) 타우피엔유메디칼 Tissue protective tube for tricuspid regurgitation
AU2016209942B2 (en) * 2015-01-20 2020-09-10 Keystone Heart Ltd. Intravascular devices and delivery systems and uses thereof
US10595895B2 (en) 2016-07-19 2020-03-24 Cardiovascular Systems, Inc. Rotational medical device with airfoil

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040181149A1 (en) * 2001-02-07 2004-09-16 Ulrich Langlotz Device and method for intraoperative navigation
US20060241740A1 (en) * 1996-11-04 2006-10-26 Advanced Stent Technologies, Inc. Extendible stent apparatus
US20080147173A1 (en) * 2006-12-18 2008-06-19 Medtronic Vascular, Inc. Prosthesis Deployment Apparatus and Methods
US20080269789A1 (en) * 2007-04-27 2008-10-30 Uri Eli Implantable device with miniature rotating portion for the treatment of atherosclerosis, especially vulnerable plaques
US20090149877A1 (en) * 2007-12-06 2009-06-11 Cardiovascular Systems, Inc. Rotational atherectomy device with pre-curved drive shaft

Family Cites Families (224)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4281669A (en) 1975-05-09 1981-08-04 Macgregor David C Pacemaker electrode with porous system
US4180613A (en) * 1977-09-01 1979-12-25 E. I. Du Pont De Nemours And Company Craze-resistant polysiloxane resin coatings and coating compositions containing a discontinuous phase
US4665906A (en) 1983-10-14 1987-05-19 Raychem Corporation Medical devices incorporating sim alloy elements
US4505767A (en) 1983-10-14 1985-03-19 Raychem Corporation Nickel/titanium/vanadium shape memory alloy
US4787899A (en) 1983-12-09 1988-11-29 Lazarus Harrison M Intraluminal graft device, system and method
US4562596A (en) 1984-04-25 1986-01-07 Elliot Kornberg Aortic graft, device and method for performing an intraluminal abdominal aortic aneurysm repair
US4617932A (en) 1984-04-25 1986-10-21 Elliot Kornberg Device and method for performing an intraluminal abdominal aortic aneurysm repair
US4577631A (en) 1984-11-16 1986-03-25 Kreamer Jeffry W Aneurysm repair apparatus and method
US4733665C2 (en) 1985-11-07 2002-01-29 Expandable Grafts Partnership Expandable intraluminal graft and method and apparatus for implanting an expandable intraluminal graft
US4878906A (en) 1986-03-25 1989-11-07 Servetus Partnership Endoprosthesis for repairing a damaged vessel
US4969458A (en) 1987-07-06 1990-11-13 Medtronic, Inc. Intracoronary stent and method of simultaneous angioplasty and stent implant
US5133732A (en) 1987-10-19 1992-07-28 Medtronic, Inc. Intravascular stent
US5782903A (en) 1987-10-19 1998-07-21 Medtronic, Inc. Intravascular stent and method
US4886062A (en) 1987-10-19 1989-12-12 Medtronic, Inc. Intravascular radially expandable stent and method of implant
US4938740A (en) 1988-05-25 1990-07-03 Trustees Of The University Of Pennsylvania Reducing stress at vascular graft anastomoses
US5509923A (en) 1989-08-16 1996-04-23 Raychem Corporation Device for dissecting, grasping, or cutting an object
US5749879A (en) 1989-08-16 1998-05-12 Medtronic, Inc. Device or apparatus for manipulating matter
US6004330A (en) 1989-08-16 1999-12-21 Medtronic, Inc. Device or apparatus for manipulating matter
US5632746A (en) 1989-08-16 1997-05-27 Medtronic, Inc. Device or apparatus for manipulating matter
US5122136A (en) 1990-03-13 1992-06-16 The Regents Of The University Of California Endovascular electrolytically detachable guidewire tip for the electroformation of thrombus in arteries, veins, aneurysms, vascular malformations and arteriovenous fistulas
US5360443A (en) 1990-06-11 1994-11-01 Barone Hector D Aortic graft for repairing an abdominal aortic aneurysm
US5064435A (en) 1990-06-28 1991-11-12 Schneider (Usa) Inc. Self-expanding prosthesis having stable axial length
EP1277442B1 (en) 1990-10-09 2008-07-30 Medtronic, Inc. Apparatus for manipulating matter
US5042707A (en) 1990-10-16 1991-08-27 Taheri Syde A Intravascular stapler, and method of operating same
US5192286A (en) * 1991-07-26 1993-03-09 Regents Of The University Of California Method and device for retrieving materials from body lumens
EP0539237A1 (en) 1991-10-25 1993-04-28 Cook Incorporated Expandable transluminal graft prosthesis for repair of aneurysm and method for implanting
US5417699A (en) 1992-12-10 1995-05-23 Perclose Incorporated Device and method for the percutaneous suturing of a vascular puncture site
US5632772A (en) 1993-10-21 1997-05-27 Corvita Corporation Expandable supportive branched endoluminal grafts
US5639278A (en) 1993-10-21 1997-06-17 Corvita Corporation Expandable supportive bifurcated endoluminal grafts
US5527322A (en) 1993-11-08 1996-06-18 Perclose, Inc. Device and method for suturing of internal puncture sites
DE9319267U1 (en) 1993-12-15 1994-02-24 Vorwerk Dierk Dr Aortic endoprosthesis
US5507769A (en) 1994-10-18 1996-04-16 Stentco, Inc. Method and apparatus for forming an endoluminal bifurcated graft
US6165210A (en) 1994-04-01 2000-12-26 Gore Enterprise Holdings, Inc. Self-expandable helical intravascular stent and stent-graft
US5554181A (en) 1994-05-04 1996-09-10 Regents Of The University Of Minnesota Stent
WO1995032671A1 (en) 1994-06-01 1995-12-07 Perclose, Inc. Method and device for providing vascular hemostasis
US5609605A (en) 1994-08-25 1997-03-11 Ethicon, Inc. Combination arterial stent
US5653743A (en) 1994-09-09 1997-08-05 Martin; Eric C. Hypogastric artery bifurcation graft and method of implantation
JP2911763B2 (en) 1994-10-27 1999-06-23 三桜子 布川 Artificial blood vessel
CA2134997C (en) 1994-11-03 2009-06-02 Ian M. Penn Stent
NL9500094A (en) 1995-01-19 1996-09-02 Industrial Res Bv Y-shaped stent and method of deployment.
US5755770A (en) 1995-01-31 1998-05-26 Boston Scientific Corporatiion Endovascular aortic graft
US5683449A (en) 1995-02-24 1997-11-04 Marcade; Jean Paul Modular bifurcated intraluminal grafts and methods for delivering and assembling same
WO1996036297A1 (en) 1995-05-19 1996-11-21 Kanji Inoue Transplantation instrument, method of bending same and method of transplanting same
US5902311A (en) 1995-06-15 1999-05-11 Perclose, Inc. Low profile intraluminal suturing device and method
US5769882A (en) 1995-09-08 1998-06-23 Medtronic, Inc. Methods and apparatus for conformably sealing prostheses within body lumens
US6071300A (en) 1995-09-15 2000-06-06 Sub-Q Inc. Apparatus and method for percutaneous sealing of blood vessel punctures
US5824040A (en) 1995-12-01 1998-10-20 Medtronic, Inc. Endoluminal prostheses and therapies for highly variable body lumens
US5676697A (en) 1996-07-29 1997-10-14 Cardiovascular Dynamics, Inc. Two-piece, bifurcated intraluminal graft for repair of aneurysm
US5728134A (en) 1996-09-17 1998-03-17 Barak; Shlomo Method and apparatus for hemostasis
US7341598B2 (en) 1999-01-13 2008-03-11 Boston Scientific Scimed, Inc. Stent with protruding branch portion for bifurcated vessels
US6325826B1 (en) 1998-01-14 2001-12-04 Advanced Stent Technologies, Inc. Extendible stent apparatus
WO1998020810A1 (en) 1996-11-12 1998-05-22 Medtronic, Inc. Flexible, radially expansible luminal prostheses
US6015431A (en) 1996-12-23 2000-01-18 Prograft Medical, Inc. Endolumenal stent-graft with leak-resistant seal
CA2235911C (en) 1997-05-27 2003-07-29 Schneider (Usa) Inc. Stent and stent-graft for treating branched vessels
US5906641A (en) 1997-05-27 1999-05-25 Schneider (Usa) Inc Bifurcated stent graft
US5984955A (en) 1997-09-11 1999-11-16 Wisselink; Willem System and method for endoluminal grafting of bifurcated or branched vessels
US6231516B1 (en) 1997-10-14 2001-05-15 Vacusense, Inc. Endoluminal implant with therapeutic and diagnostic capability
US6033435A (en) 1997-11-03 2000-03-07 Divysio Solutions Ulc Bifurcated stent and method for the manufacture and delivery of same
US6099497A (en) 1998-03-05 2000-08-08 Scimed Life Systems, Inc. Dilatation and stent delivery system for bifurcation lesions
US6129756A (en) 1998-03-16 2000-10-10 Teramed, Inc. Biluminal endovascular graft system
US6224609B1 (en) 1998-03-16 2001-05-01 Teramed Inc. Bifurcated prosthetic graft
US6325820B1 (en) 1998-11-16 2001-12-04 Endotex Interventional Systems, Inc. Coiled-sheet stent-graft with exo-skeleton
US6692520B1 (en) 1998-12-15 2004-02-17 C. R. Bard, Inc. Systems and methods for imbedded intramuscular implants
US6059824A (en) 1998-12-23 2000-05-09 Taheri; Syde A. Mated main and collateral stent and method for treatment of arterial disease
US6200339B1 (en) 1999-02-23 2001-03-13 Datascope Investment Corp. Endovascular split-tube bifurcated graft prosthesis and an implantation method for such a prosthesis
US6544279B1 (en) * 2000-08-09 2003-04-08 Incept, Llc Vascular device for emboli, thrombus and foreign body removal and methods of use
US7662161B2 (en) 1999-09-13 2010-02-16 Rex Medical, L.P Vascular hole closure device
EP1211983B1 (en) 1999-09-13 2007-03-07 Rex Medical, LP Vascular closure
US20020198585A1 (en) 1999-10-05 2002-12-26 Willem Wisselink System and method for edoluminal grafting of bifurcated or branched vessels
AU1084101A (en) 1999-10-14 2001-04-23 United Stenting, Inc. Stents with multilayered struts
US6325823B1 (en) 1999-10-29 2001-12-04 Revasc Corporation Endovascular prosthesis accommodating torsional and longitudinal displacements and methods of use
US6652567B1 (en) 1999-11-18 2003-11-25 David H. Deaton Fenestrated endovascular graft
US6280466B1 (en) 1999-12-03 2001-08-28 Teramed Inc. Endovascular graft system
US6663667B2 (en) 1999-12-29 2003-12-16 Edwards Lifesciences Corporation Towel graft means for enhancing tissue ingrowth in vascular grafts
US6537311B1 (en) 1999-12-30 2003-03-25 Advanced Cardiovascular Systems, Inc. Stent designs for use in peripheral vessels
US6692513B2 (en) * 2000-06-30 2004-02-17 Viacor, Inc. Intravascular filter with debris entrapment mechanism
US6814752B1 (en) 2000-03-03 2004-11-09 Endovascular Technologies, Inc. Modular grafting system and method
US6942691B1 (en) 2000-04-27 2005-09-13 Timothy A. M. Chuter Modular bifurcated graft for endovascular aneurysm repair
US6846321B2 (en) 2000-06-21 2005-01-25 Cardiodex, Ltd. Mechanical method and apparatus for enhancing hemostatis following arterial catheterization
US6613078B1 (en) 2000-08-02 2003-09-02 Hector Daniel Barone Multi-component endoluminal graft assembly, use thereof and method of implanting
US6695833B1 (en) 2000-09-27 2004-02-24 Nellix, Inc. Vascular stent-graft apparatus and forming method
WO2002030329A2 (en) 2000-10-13 2002-04-18 Rex Medical, L.P. Covered stents with side branch
US7029481B1 (en) 2000-11-06 2006-04-18 Abbott Laboratories Systems, devices and methods for suturing patient tissue
US6506211B1 (en) 2000-11-13 2003-01-14 Scimed Life Systems, Inc. Stent designs
US7229472B2 (en) 2000-11-16 2007-06-12 Cordis Corporation Thoracic aneurysm repair prosthesis and system
JP4532070B2 (en) 2000-11-17 2010-08-25 エビーシオ・メディカル・デバイセズ・ユーエルシー Endovascular prosthesis
US20040106972A1 (en) 2000-11-20 2004-06-03 Deaton David H. Fenestrated endovascular graft
US8870946B1 (en) 2000-12-11 2014-10-28 W.L. Gore & Associates, Inc. Method of deploying a bifurcated side-access intravascular stent graft
US6929660B1 (en) 2000-12-22 2005-08-16 Advanced Cardiovascular Systems, Inc. Intravascular stent
US20020123791A1 (en) 2000-12-28 2002-09-05 Harrison William J. Stent design with increased vessel coverage
US6673080B2 (en) * 2001-01-08 2004-01-06 Scimed Life Systems, Inc. Retrieval basket with releasable tip
US6445953B1 (en) 2001-01-16 2002-09-03 Kenergy, Inc. Wireless cardiac pacing system with vascular electrode-stents
JP4673987B2 (en) 2001-02-27 2011-04-20 株式会社トップ Stent and stent member
US6743195B2 (en) 2001-03-14 2004-06-01 Cardiodex Balloon method and apparatus for vascular closure following arterial catheterization
US20020183783A1 (en) * 2001-06-04 2002-12-05 Shadduck John H. Guidewire for capturing emboli in endovascular interventions
US6824560B2 (en) 2001-06-13 2004-11-30 Advanced Cardiovascular Systems, Inc. Double-butted superelastic nitinol tubing
US6635083B1 (en) 2001-06-25 2003-10-21 Advanced Cardiovascular Systems, Inc. Stent with non-linear links and method of use
AUPR748801A0 (en) 2001-09-04 2001-09-27 Stentco Llc A stent
US7749243B2 (en) * 2001-10-19 2010-07-06 Boston Scientific Scimed, Inc. Embolus extractor
US8740973B2 (en) 2001-10-26 2014-06-03 Icon Medical Corp. Polymer biodegradable medical device
AUPR847201A0 (en) 2001-10-26 2001-11-15 Cook Incorporated Endoluminal graft
US6776794B1 (en) 2001-11-28 2004-08-17 Advanced Cardiovascular Systems, Inc. Stent pattern with mirror image
US20030212449A1 (en) 2001-12-28 2003-11-13 Cox Daniel L. Hybrid stent
US20030130720A1 (en) 2002-01-08 2003-07-10 Depalma Donald F. Modular aneurysm repair system
EP1336392A1 (en) 2002-02-14 2003-08-20 John S. Geis Body vessel support and catheter system
US7192434B2 (en) * 2002-03-08 2007-03-20 Ev3 Inc. Vascular protection devices and methods of use
US8545549B2 (en) 2002-03-25 2013-10-01 Cook Medical Technologies Llc Bifurcated/branch vessel prosthesis
US7717934B2 (en) * 2002-06-14 2010-05-18 Ev3 Inc. Rapid exchange catheters usable with embolic protection devices
US7044962B2 (en) 2002-06-25 2006-05-16 Scimed Life Systems, Inc. Implantable prosthesis with displaceable skirt
US7232459B2 (en) 2002-06-28 2007-06-19 Cook Incorporated Thoracic aortic aneurysm stent graft
AU2003258337A1 (en) 2002-08-23 2004-03-11 Cook Incorporated Asymmetric stent graft attachment
US8518096B2 (en) 2002-09-03 2013-08-27 Lifeshield Sciences Llc Elephant trunk thoracic endograft and delivery system
US7371256B2 (en) 2002-12-16 2008-05-13 Poly-Med, Inc Composite vascular constructs with selectively controlled properties
CA2512610C (en) 2003-01-14 2008-12-23 The Cleveland Clinic Foundation Branched vessel endoluminal device
US7407509B2 (en) 2003-01-14 2008-08-05 The Cleveland Clinic Foundation Branched vessel endoluminal device with fenestration
US7115127B2 (en) 2003-02-04 2006-10-03 Cardiodex, Ltd. Methods and apparatus for hemostasis following arterial catheterization
US7223266B2 (en) 2003-02-04 2007-05-29 Cardiodex Ltd. Methods and apparatus for hemostasis following arterial catheterization
US7025779B2 (en) 2003-02-26 2006-04-11 Scimed Life Systems, Inc. Endoluminal device having enhanced affixation characteristics
WO2004089249A1 (en) 2003-04-03 2004-10-21 William A. Cook Australia Pty. Ltd. Branch stent graft deployment and method
US7279003B2 (en) 2003-04-24 2007-10-09 Medtronic Vascular, Inc. Stent graft tapered spring
US7438721B2 (en) 2003-04-25 2008-10-21 Medtronic Vascular, Inc. Universal modular stent graft assembly to accommodate flow to collateral branches
US7429269B2 (en) 2003-07-08 2008-09-30 Ventor Technologies Ltd. Aortic prosthetic devices
US7201772B2 (en) 2003-07-08 2007-04-10 Ventor Technologies, Ltd. Fluid flow prosthetic device
US20050033406A1 (en) 2003-07-15 2005-02-10 Barnhart William H. Branch vessel stent and graft
US7763063B2 (en) 2003-09-03 2010-07-27 Bolton Medical, Inc. Self-aligning stent graft delivery system, kit, and method
US7789891B2 (en) 2003-09-23 2010-09-07 Boston Scientific Scimed, Inc. External activation of vaso-occlusive implants
AU2004279459B2 (en) 2003-10-10 2010-12-02 Cook Incorporated Stent graft fenestration
WO2005034810A1 (en) 2003-10-10 2005-04-21 Cook Incorporated Stretchable prosthesis fenestration
WO2005037133A2 (en) 2003-10-10 2005-04-28 Arshad Quadri System and method for endoluminal grafting of bifurcated and branched vessels
EP1684666A4 (en) 2003-10-14 2010-04-07 James C Peacock Iii Aneurysm treatment system and method
GB2423028B (en) 2003-10-30 2007-12-19 Sunshine Heart Co Pty Ltd A wrap
US20070167898A1 (en) 2003-10-30 2007-07-19 Sunshine Heart Company Pty Ltd. Methods and devices for tensioning a wrap around a blood vessel
US7144421B2 (en) 2003-11-06 2006-12-05 Carpenter Judith T Endovascular prosthesis, system and method
US9078780B2 (en) 2003-11-08 2015-07-14 Cook Medical Technologies Llc Balloon flareable branch vessel prosthesis and method
US20050203606A1 (en) 2004-03-09 2005-09-15 Vancamp Daniel H. Stent system for preventing restenosis
US8715340B2 (en) 2004-03-31 2014-05-06 Merlin Md Pte Ltd. Endovascular device with membrane
US8048140B2 (en) 2004-03-31 2011-11-01 Cook Medical Technologies Llc Fenestrated intraluminal stent system
AU2005262541B2 (en) 2004-06-16 2011-04-21 Cook Incorporated Thoracic deployment device and stent graft
US20060015170A1 (en) 2004-07-16 2006-01-19 Jones Ryan A Contrast coated stent and method of fabrication
ATE389370T1 (en) 2004-09-02 2008-04-15 Med Inst Inc MODULAR PROSTHESIS AND METHODS FOR BRANCH VESSELS
US20060069426A1 (en) 2004-09-27 2006-03-30 Weinberger Judah Z Methods and devices for extravascular intervention
US8287583B2 (en) 2005-01-10 2012-10-16 Taheri Laduca Llc Apparatus and method for deploying an implantable device within the body
US20070150051A1 (en) 2005-01-10 2007-06-28 Duke Fiduciary, Llc Vascular implants and methods of fabricating the same
US20060155366A1 (en) 2005-01-10 2006-07-13 Laduca Robert Apparatus and method for deploying an implantable device within the body
US7306623B2 (en) 2005-01-13 2007-12-11 Medtronic Vascular, Inc. Branch vessel graft design and deployment method
US7544160B2 (en) 2005-02-10 2009-06-09 Yossi Gross Extracardiac blood flow amplification device
US20060229709A1 (en) 2005-03-30 2006-10-12 Morris Liam G Vascular graft
US7637939B2 (en) 2005-06-30 2009-12-29 Boston Scientific Scimed, Inc. Hybrid stent
WO2007014088A2 (en) 2005-07-25 2007-02-01 Cook Incorporated Intraluminal prosthesis and stent
US7473272B2 (en) 2005-08-17 2009-01-06 Medtronic Vascular, Inc. Recapturable stent with minimum crossing profile
EP1915106B1 (en) 2005-08-18 2018-04-04 Cook Medical Technologies LLC Method of manufacturing fenestrated stent grafts
US20070055358A1 (en) 2005-08-22 2007-03-08 Krolik Jeffrey A Axially compressible flared stents and apparatus and methods for delivering them
WO2007028086A2 (en) 2005-09-01 2007-03-08 Medtronic Vascular, Inc. Methods and apparatus for treatment of thoracic aortic aneurysms
US7955374B2 (en) 2005-09-02 2011-06-07 Medtronic Vascular, Inc. Modular branch vessel stent-graft assembly
EP1933764A2 (en) 2005-09-02 2008-06-25 Medtronic Vascular, Inc. Methods and apparatus for treatment of aneurysms adjacent to branch arteries
US20070060989A1 (en) 2005-09-07 2007-03-15 Deem Mark E Apparatus and method for disrupting subcutaneous structures
WO2007038476A2 (en) 2005-09-26 2007-04-05 Atteneux Technologies, Inc. Pressure attenuation device
US8562666B2 (en) 2005-09-28 2013-10-22 Nitinol Development Corporation Intraluminal medical device with nested interlocking segments
US7670369B2 (en) 2005-10-13 2010-03-02 Cook Incorporated Endoluminal prosthesis
WO2007053592A2 (en) 2005-10-31 2007-05-10 Cook Incorporated Composite stent graft
WO2007054015A1 (en) 2005-11-09 2007-05-18 Ning Wen An artificial heart valve stent and weaving method thereof
US7540881B2 (en) 2005-12-22 2009-06-02 Boston Scientific Scimed, Inc. Bifurcation stent pattern
CA2636794C (en) 2006-01-18 2014-08-12 William A. Cook Australia Pty. Ltd. Endoluminal delivery device
US8211168B2 (en) 2006-02-21 2012-07-03 Cook Biotech Incorporated Graft material, stent graft and method
US9155641B2 (en) 2006-03-09 2015-10-13 Cook Medical Technologies Llc Expandable stent grafts
US20070219610A1 (en) 2006-03-20 2007-09-20 Israel Henry M Stent with flap
US20070244547A1 (en) 2006-04-18 2007-10-18 Medtronic Vascular, Inc., A Delaware Corporation Device and Method for Controlling the Positioning of a Stent Graft Fenestration
US7678141B2 (en) 2006-04-18 2010-03-16 Medtronic Vascular, Inc. Stent graft having a flexible, articulable, and axially compressible branch graft
US8066760B2 (en) 2006-04-18 2011-11-29 Medtronic Vascular, Inc. Stent with movable crown
EP1849440A1 (en) 2006-04-28 2007-10-31 Younes Boudjemline Vascular stents with varying diameter
DE102006024242A1 (en) 2006-05-23 2007-11-29 Siemens Ag X-ray system`s deviation detecting method for e.g. medical examination device, involves recording current image of actual position of measuring object by x-ray system, and comparing current image with provided reference image of object
US8632581B2 (en) 2006-07-10 2014-01-21 Cook Medical Technologies Llc Conformable end sealing stent
WO2008008291A2 (en) 2006-07-13 2008-01-17 Icon Medical Corp. Stent
US8348996B2 (en) 2006-09-19 2013-01-08 Medtronic Ventor Technologies Ltd. Valve prosthesis implantation techniques
JP2010504820A (en) 2006-09-28 2010-02-18 クック・インコーポレイテッド Apparatus and method for repairing a thoracic aortic aneurysm
GB0620495D0 (en) 2006-10-16 2006-11-22 Anson Medical Ltd Apparatus and method for positioning a stent graft
EP2083901B1 (en) 2006-10-16 2017-12-27 Medtronic Ventor Technologies Ltd. Transapical delivery system with ventriculo-arterial overflow bypass
EP2079397B1 (en) 2006-10-24 2010-03-24 Cook Incorporated Stent member
WO2008053469A2 (en) 2006-10-29 2008-05-08 Alon Shalev An extra-vascular wrapping for treating aneurysmatic aorta and methods thereof
US20090099648A1 (en) 2006-11-09 2009-04-16 Chun Ho Yu Modular stent graft and delivery system
US8216298B2 (en) 2007-01-05 2012-07-10 Medtronic Vascular, Inc. Branch vessel graft method and delivery system
EP2142142B1 (en) 2007-03-05 2017-02-08 Endospan Ltd Multi-component expandable supportive bifurcated endoluminal grafts and methods for using same
AU2008251804B2 (en) 2007-05-11 2013-01-10 Cook Incorporated Stent grafts for the thoracic aorta
US20080319528A1 (en) 2007-06-25 2008-12-25 Abbott Laboratories Modular endoprosthesis with flexible interconnectors between modules
US20090030502A1 (en) 2007-07-26 2009-01-29 Jichao Sun Socket For Fenestrated Tubular Prosthesis
CA2695679C (en) 2007-08-08 2015-12-01 Cleveland Clinic Foundation Branched stent graft system
US7771455B2 (en) 2007-08-31 2010-08-10 Ken Christopher G M Closure medical device
US20090082847A1 (en) 2007-09-26 2009-03-26 Boston Scientific Corporation System and method of securing stent barbs
AU2008308474B2 (en) 2007-10-04 2014-07-24 Trivascular, Inc. Modular vascular graft for low profile percutaneous delivery
EP3505142B1 (en) 2007-10-19 2020-10-28 CeloNova Biosciences, Inc. Implantable and lumen-supporting stents
US20090112233A1 (en) 2007-10-30 2009-04-30 Medtronic Vascular, Inc. Prosthesis Fixation Apparatus and Methods
US20090125096A1 (en) 2007-11-12 2009-05-14 Medtronic Vascular, Inc. Stent Graft With Pins
US8486131B2 (en) 2007-12-15 2013-07-16 Endospan Ltd. Extra-vascular wrapping for treating aneurysmatic aorta in conjunction with endovascular stent-graft and methods thereof
US8574284B2 (en) 2007-12-26 2013-11-05 Cook Medical Technologies Llc Low profile non-symmetrical bare alignment stents with graft
CA2711176C (en) 2007-12-26 2015-09-15 Medical Engineering And Development Institute, Inc. Stent and method of making a stent
US8313525B2 (en) 2008-03-18 2012-11-20 Medtronic Ventor Technologies, Ltd. Valve suturing and implantation procedures
US8696689B2 (en) 2008-03-18 2014-04-15 Medtronic Ventor Technologies Ltd. Medical suturing device and method for use thereof
US8100960B2 (en) 2008-03-20 2012-01-24 Medtronic Vascular, Inc. Bloused stent-graft and fenestration method
IL190438A0 (en) 2008-03-25 2008-12-29 K M B Y Ltd A method of setting a drill for drilling a hole in a bone coaxial to the hole in the nail and aiming device for realizing this method
US7806919B2 (en) 2008-04-01 2010-10-05 Medtronic Vascular, Inc. Double-walled stent system
US20090259290A1 (en) 2008-04-14 2009-10-15 Medtronic Vascular, Inc. Fenestration Segment Stent-Graft and Fenestration Method
US20090287145A1 (en) 2008-05-15 2009-11-19 Altura Interventional, Inc. Devices and methods for treatment of abdominal aortic aneurysms
US8911488B2 (en) 2008-08-26 2014-12-16 The Cleveland Clinic Foundation Thoracic introducer
JP5574123B2 (en) 2008-08-26 2014-08-20 クック メディカル テクノロジーズ エルエルシー Thoracic aortic stent graft with access region
US8998981B2 (en) 2008-09-15 2015-04-07 Medtronic, Inc. Prosthetic heart valve having identifiers for aiding in radiographic positioning
US8137398B2 (en) 2008-10-13 2012-03-20 Medtronic Ventor Technologies Ltd Prosthetic valve having tapered tip when compressed for delivery
GB2464977B (en) 2008-10-31 2010-11-03 William Cook Europe As Introducer for deploying a stent graft in a curved lumen and stent graft therefor
RU2566225C2 (en) 2009-02-09 2015-10-20 ЭВИЗИО МЕДИКАЛ ДЕВАЙСИЗ ЮЭлСи Stent
GB2470083A (en) 2009-05-08 2010-11-10 Nat Univ Ireland Closed loop stent
CA3009244C (en) 2009-06-23 2020-04-28 Endospan Ltd. Vascular prostheses for treating aneurysms
CA2767596C (en) 2009-07-09 2015-11-24 Endospan Ltd. Apparatus for closure of a lumen and methods of using the same
CA2768228C (en) 2009-07-14 2015-08-18 Endospan Ltd. Sideport engagement and sealing mechanism for endoluminal stent-grafts
US20110093002A1 (en) 2009-10-20 2011-04-21 Wilson-Cook Medical Inc. Stent-within-stent arrangements
EP2496178A1 (en) 2009-11-04 2012-09-12 Endospan Ltd Treatment of a main body lumen in the vicinity of a branching body lumen
EP3735937A1 (en) 2009-11-30 2020-11-11 Endospan Ltd. Multi-component stent-graft system for implantation in a blood vessel with multiple branches
EP2506809A4 (en) 2009-12-02 2016-10-26 Endospan Ltd Endovascular fenestrated stent-grafting
WO2011070576A1 (en) 2009-12-08 2011-06-16 Endospan Ltd. Endovascular stent-graft system with fenestrated and crossing stent-grafts
CA2785953C (en) 2009-12-31 2016-02-16 Endospan Ltd. Endovascular flow direction indicator
US9468517B2 (en) 2010-02-08 2016-10-18 Endospan Ltd. Thermal energy application for prevention and management of endoleaks in stent-grafts
US10433956B2 (en) 2010-02-24 2019-10-08 Medtronic Ventor Technologies Ltd. Mitral prosthesis and methods for implantation
US9414914B2 (en) 2010-02-24 2016-08-16 Medtronic Ventor Technologies Ltd. Catheter assembly with valve crimping accessories
US20110208289A1 (en) 2010-02-25 2011-08-25 Endospan Ltd. Flexible Stent-Grafts
US20110264184A1 (en) 2010-04-26 2011-10-27 Paul Heltai Sleeve and tubing device for restricting and constricting aneurysms and a system and method for using such a device
US9402754B2 (en) 2010-05-18 2016-08-02 Abbott Cardiovascular Systems, Inc. Expandable endoprostheses, systems, and methods for treating a bifurcated lumen

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060241740A1 (en) * 1996-11-04 2006-10-26 Advanced Stent Technologies, Inc. Extendible stent apparatus
US20040181149A1 (en) * 2001-02-07 2004-09-16 Ulrich Langlotz Device and method for intraoperative navigation
US20080147173A1 (en) * 2006-12-18 2008-06-19 Medtronic Vascular, Inc. Prosthesis Deployment Apparatus and Methods
US20080269789A1 (en) * 2007-04-27 2008-10-30 Uri Eli Implantable device with miniature rotating portion for the treatment of atherosclerosis, especially vulnerable plaques
US20090149877A1 (en) * 2007-12-06 2009-06-11 Cardiovascular Systems, Inc. Rotational atherectomy device with pre-curved drive shaft

Cited By (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8317856B2 (en) 2007-03-05 2012-11-27 Endospan Ltd. Multi-component expandable supportive bifurcated endoluminal grafts and methods for using same
US8709068B2 (en) 2007-03-05 2014-04-29 Endospan Ltd. Multi-component bifurcated stent-graft systems
US8486131B2 (en) 2007-12-15 2013-07-16 Endospan Ltd. Extra-vascular wrapping for treating aneurysmatic aorta in conjunction with endovascular stent-graft and methods thereof
US11090148B2 (en) 2009-06-23 2021-08-17 Endospan Ltd. Vascular prosthesis for treating aneurysms
US8870938B2 (en) 2009-06-23 2014-10-28 Endospan Ltd. Vascular prostheses for treating aneurysms
US9918825B2 (en) 2009-06-23 2018-03-20 Endospan Ltd. Vascular prosthesis for treating aneurysms
US8979892B2 (en) 2009-07-09 2015-03-17 Endospan Ltd. Apparatus for closure of a lumen and methods of using the same
US10888413B2 (en) 2009-11-30 2021-01-12 Endospan Ltd. Multi-component stent-graft system for implantation in a blood vessel with multiple branches
US10201413B2 (en) 2009-11-30 2019-02-12 Endospan Ltd. Multi-component stent-graft system for implantation in a blood vessel with multiple branches
US8945203B2 (en) 2009-11-30 2015-02-03 Endospan Ltd. Multi-component stent-graft system for implantation in a blood vessel with multiple branches
US9101457B2 (en) 2009-12-08 2015-08-11 Endospan Ltd. Endovascular stent-graft system with fenestrated and crossing stent-grafts
US8956397B2 (en) 2009-12-31 2015-02-17 Endospan Ltd. Endovascular flow direction indicator
US9468517B2 (en) 2010-02-08 2016-10-18 Endospan Ltd. Thermal energy application for prevention and management of endoleaks in stent-grafts
US9526638B2 (en) 2011-02-03 2016-12-27 Endospan Ltd. Implantable medical devices constructed of shape memory material
US9855046B2 (en) 2011-02-17 2018-01-02 Endospan Ltd. Vascular bands and delivery systems therefor
US9486341B2 (en) 2011-03-02 2016-11-08 Endospan Ltd. Reduced-strain extra-vascular ring for treating aortic aneurysm
US8574287B2 (en) 2011-06-14 2013-11-05 Endospan Ltd. Stents incorporating a plurality of strain-distribution locations
US8951298B2 (en) 2011-06-21 2015-02-10 Endospan Ltd. Endovascular system with circumferentially-overlapping stent-grafts
US9254209B2 (en) 2011-07-07 2016-02-09 Endospan Ltd. Stent fixation with reduced plastic deformation
US9839510B2 (en) 2011-08-28 2017-12-12 Endospan Ltd. Stent-grafts with post-deployment variable radial displacement
US9427339B2 (en) 2011-10-30 2016-08-30 Endospan Ltd. Triple-collar stent-graft
US9597204B2 (en) 2011-12-04 2017-03-21 Endospan Ltd. Branched stent-graft system
US9770350B2 (en) 2012-05-15 2017-09-26 Endospan Ltd. Stent-graft with fixation elements that are radially confined for delivery
WO2014020609A1 (en) 2012-08-01 2014-02-06 Endospan Ltd. Stent-grafts configured for post-implantation expansion
US9993360B2 (en) 2013-01-08 2018-06-12 Endospan Ltd. Minimization of stent-graft migration during implantation
US9668892B2 (en) 2013-03-11 2017-06-06 Endospan Ltd. Multi-component stent-graft system for aortic dissections
US10603197B2 (en) 2013-11-19 2020-03-31 Endospan Ltd. Stent system with radial-expansion locking
US10485684B2 (en) 2014-12-18 2019-11-26 Endospan Ltd. Endovascular stent-graft with fatigue-resistant lateral tube
US11419742B2 (en) 2014-12-18 2022-08-23 Endospan Ltd. Endovascular stent-graft with fatigue-resistant lateral tube

Also Published As

Publication number Publication date
CA2785953C (en) 2016-02-16
EP2519166A1 (en) 2012-11-07
US8956397B2 (en) 2015-02-17
US20120316634A1 (en) 2012-12-13
EP2519166A4 (en) 2017-06-14
CA2785953A1 (en) 2011-07-07

Similar Documents

Publication Publication Date Title
CA2785953C (en) Endovascular flow direction indicator
US20210196491A1 (en) Apparatus and method of placement of a graft or graft system
US11779454B2 (en) Vascular prosthesis with crimped adapter and methods of use
CN109561958B (en) Vascular medical devices and systems
US9314360B2 (en) Bi-directional stent delivery system
JP6522483B2 (en) Pre-mounted wire for intraluminal devices
US8337546B2 (en) Mobile external coupling for branch vessel connection
JP5156936B2 (en) A fenestration stent graft and its sizing method
US20190247178A1 (en) Vascular Prosthesis with Moveable Fenestration and Method of Use
US6918926B2 (en) System for transrenal/intraostial fixation of endovascular prosthesis
JP4291971B2 (en) Modified guidewire access modulator endoluminal prosthesis with connections
JP6714361B2 (en) Visceral-sided twin-tube main body stent graft and method of use
JP2019524274A (en) Systems, instruments, and methods for coupling an artificial implant to a fenestrated body
US20140350658A1 (en) Branched stent-graft system
WO2018156847A1 (en) Delivery system and method to radially constrict a stent graft
US20110270379A1 (en) Mobile External Coupling for Branch Vessel Connection
AU2010248822A1 (en) Low-profile modular abdominal aortic aneurysm graft
JP2017074405A (en) Endoluminal prosthesis having modular branches and methods of deployment
CA2837065C (en) Stent cannulation guiding device and method of use

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 10840702

Country of ref document: EP

Kind code of ref document: A1

WWE Wipo information: entry into national phase

Ref document number: 2010840702

Country of ref document: EP

ENP Entry into the national phase

Ref document number: 2785953

Country of ref document: CA

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 13519971

Country of ref document: US